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Abstract
Background—Smoking contributes to reasons for hospitalisation, and the period of 
hospitalisation may be a good time to provide help with quitting.
Objectives—To determine the effectiveness of interventions for smoking cessation that are 
initiated for hospitalised patients.
Search methods—We searched the Cochrane Tobacco Addiction Group register which 
includes papers identified from CENTRAL, MEDLINE, EMBASE and PsycINFO in December 
2011 for studies of interventions for smoking cessation in hospitalised patients, using terms 
including (hospital and patient*) or hospitali* or inpatient* or admission* or admitted.
Selection criteria—Randomized and quasi-randomized trials of behavioural, pharmacological 
or multicomponent interventions to help patients stop smoking, conducted with hospitalised 
patients who were current smokers or recent quitters (defined as having quit more than one month 
before hospital admission). The intervention had to start in the hospital but could continue after 
hospital discharge. We excluded studies of patients admitted to facilities that primarily treat 
psychiatric disorders or substance abuse, studies that did not report abstinence rates and studies 
with follow-up of less than six months. Both acute care hospitals and rehabilitation hospitals were 
included in this update, with separate analyses done for each type of hospital.
Data collection and analysis—Two authors extracted data independently for each paper, with 
disagreements resolved by consensus.
Main results—Fifty trials met the inclusion criteria. Intensive counselling interventions that 
began during the hospital stay and continued with supportive contacts for at least one month after 
discharge increased smoking cessation rates after discharge (risk ratio (RR) 1.37, 95% confidence 
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interval (CI) 1.27 to 1.48; 25 trials). A specific benefit for post-discharge contact compared with 
usual care was found in a subset of trials in which all participants received a counselling 
intervention in the hospital and were randomly assigned to post-discharge contact or usual care. 
No statistically significant benefit was found for less intensive counselling interventions. Adding 
nicotine replacement therapy (NRT) to an intensive counselling intervention increased smoking 
cessation rates compared with intensive counselling alone (RR 1.54, 95% CI 1.34 to 1.79, six 
trials). Adding varenicline to intensive counselling had a non-significant effect in two trials (RR 
1.28, 95% CI 0.95 to 1.74). Adding bupropion did not produce a statistically significant increase 
in cessation over intensive counselling alone (RR 1.04, 95% CI 0.75 to 1.45, three trials). A 
similar pattern of results was observed in a subgroup of smokers admitted to hospital because of 
cardiovascular disease (CVD). In this subgroup, intensive intervention with follow-up support 
increased the rate of smoking cessation (RR 1.42, 95% CI 1.29 to 1.56), but less intensive 
interventions did not. One trial of intensive intervention including counselling and 
pharmacotherapy for smokers admitted with CVD assessed clinical and health care utilization 
endpoints, and found significant reductions in all-cause mortality and hospital readmission rates 
over a two-year follow-up period. These trials were all conducted in acute care hospitals. A 
comparable increase in smoking cessation rates was observed in a separate pooled analysis of 
intensive counselling interventions in rehabilitation hospitals (RR 1.71, 95% CI 1.37 to 2.14, three 
trials).
Authors' conclusions—High intensity behavioural interventions that begin during a hospital 
stay and include at least one month of supportive contact after discharge promote smoking 
cessation among hospitalised patients. These interventions are effective regardless of the patient's 
admitting diagnosis and are effective in rehabilitation settings as well as acute care hospitals. 
lnterventions of lower intensity or shorter duration have not been shown to be effective in this 
setting. This update found that adding NRT to intensive counselling significantly increases 
cessation rates over counselling alone. There is insufficient direct evidence to conclude that 
adding bupropion or varenicline to intensive counselling increases cessation rates over what is 
achieved by counselling alone.
Plain language summary
Interventions started during hospitalisation to help people to stop smoking
Smoking contributes to many health problems including cancers, cardiovascular disease and 
lung diseases. Smoking also increases the risk associated with hospitalisation for surgery. 
People who are in hospital because of a smoking-related illness are likely to be more 
receptive to help to give up smoking. Our review of fifty trials found that effective 
programmes to stop smoking are those that begin during a hospital stay and include 
counselling with follow-up support for at least one month after discharge. Such programmes 
are effective when administered to all hospitalised smokers, regardless of the reason why 
they were admitted to hospital, and in the subset of smokers who are admitted to hospital 
with cardiovascular disease. Adding nicotine replacement therapy to a counselling program 
increases the success rate of a program for hospitalised smokers.
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Background
Smoking contributes to many of the health problems leading to hospitalisation, particularly 
vascular disease, respiratory illness and many cancers. In addition, smoking increases the 
risk associated with hospitalisations for surgical procedures. Hospitalisation, especially for a 
tobacco-related illness, may boost receptivity to smoking cessation messages by increasing 
perceived vulnerability, a so-called 'teachable moment'. Illness also brings smokers to the 
healthcare setting, where they have contact with health professionals who can provide a 
smoking cessation message or intervention. In addition, procedures such as coronary 
arteriography that provide detail of the patient's cardiac status may minimise subsequent 
denial of cardiac risk by the patient (Ockene 1992). Many hospitals restrict or prohibit 
smoking by patients to protect patients and staff from secondhand smoke exposure. This 
smoke-free environment may also provide an opportunity for smokers to try out tobacco 
abstinence away from the usual environmental cues to smoke. For these reasons, providing 
(or at least initiating) tobacco dependence treatments in hospitals may be an effective 
preventive health strategy.
A number of studies have evaluated smoking cessation services provided or initiated in 
hospital. The interventions have included behavioural counselling of different forms and 
intensity (including post-hospitalisation contacts), pharmacological therapies (such as 
nicotine replacement therapy [NRT], bupropion and varenicline), and combinations of 
counselling and pharmacotherapy. The aim of this review is to evaluate the effectiveness of 
smoking cessation interventions initiated during a hospital stay. In order to inform policy, 
we aimed to identify the components of effective programmes. In addition, we aimed to 
explore whether there is a difference in effect according to the reason for hospitalisation or 
whether the effect holds for patients with a variety of admission diagnoses, and whether the 
effect of interventions in acute care hospitals is also observed in rehabilitation hospitals.
Objectives
The primary objective was to determine the efficacy of any type of smoking cessation 
programme for hospitalised patients. Our hypotheses were that:
• Systematic behavioural intervention (brief advice, individual counselling, provision 
of self-help materials, group therapy) increases quit rates more than usual care, and 
intensive intervention increases quit rates more than brief intervention.
• Interventions that occur both in hospital and after discharge increase quit rates 
more than interventions limited to the hospital stay, and longer post-discharge 
follow-up increases quit rates more than short follow-up.
• Adding pharmacotherapy (such as NRT, bupropion or varenicline) to a behavioural 
intervention increases quit rates more than placebo or no medication, and 
combining pharmacotherapy with a behavioural intervention increases quit rates 
more than either alone.
A secondary objective was to explore the possibility that the efficacy of interventions 
differed for patients with different diagnoses. This was done using subgroup analysis of 
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trials that recruited patients from more than one specialty, and by indirect comparison of 
trials that recruited patients from within one disease category. The primary review focuses 
on interventions for smokers who are admitted to an acute care hospital. Studies of 
interventions for smokers in rehabilitation hospitals have now been published. This update 
includes a new separate review of the efficacy of smoking interventions initiated during a 
stay in a rehabilitation hospital.
Methods
Criteria for considering studies for this review
Types of studies—Randomized or quasi-randomized controlled trials.
Types of participants—Participants were patients who were hospitalised and who were 
currently smoking (defined as having smoked within one month of hospital admission) or 
had recently quit (defined as having quit more than one month before hospital admission). 
We excluded trials of secondary prevention or cardiac rehabilitation that did not recruit on 
the basis of smoking history, and trials in patients hospitalised in facilities that primarily 
treated psychiatric disorders or substance abuse (including inpatient tobacco addiction 
programmes). We included interventions that began in either acute care hospitals or 
rehabilitation hospitals. We included trials that recruited all hospitalised smokers and those 
limited to patients who planned to quit smoking after hospital discharge. Trials in which 
'recent quitters' were classified as smokers were included, but a sensitivity analysis was 
performed on these data to determine whether they differed from trials that excluded such 
individuals.
Types of interventions—Any intervention that was initiated during hospitalisation and 
that aimed to increase motivation to quit, to assist a quit attempt, or to help recent quitters 
avoid relapse was included. Interventions that began in hospital and continued after 
discharge were included. The intervention could be delivered by physicians, nursing staff, 
psychologists, smoking cessation counsellors or other hospital staff. The intervention could 
include advice, more intensive behavioural therapy, or smoking cessation pharmacotherapy, 
with or without continued contact after hospital discharge. The control intervention could be 
any less intensive intervention, such as brief advice to quit, or it could be usual care. Studies 
that provided identical treatment consisting of more than usual or minimal care during the 
hospital stay and then randomly assigned participants to different post-discharge 
interventions were analysed separately in a sensitivity analysis. We included studies of 
smoking interventions that were part of a broader risk reduction or rehabilitation programme 
only if it was possible to extract data on the outcome effects of the smoking cessation 
component specifically, and if details of the nature of the intervention and control were 
explicitly stated. We included studies that reported the use of NRT, bupropion, varenicline, 
or other pharmacotherapy for smoking cessation.
We categorised behavioural interventions during the hospital stay according to whether they 
included follow-up after discharge. Within these categories we further defined both the 
hospital and follow-up interventions by level of intensity. This led to four categories of 
intervention intensity:
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1. Single contact in hospital lasting <= 15 minutes, no follow-up support.
2. One or more contacts in hospital lasting in total > 15 minutes, no follow-up 
support.
3. Any hospital contact plus follow-up <=1 month.
4. Any hospital contact plus follow-up > 1 month.
Types of outcome measures—The principal outcome measure was abstinence from 
smoking at least six months after the start of the intervention. We used the most 
conservative measure of quitting at the longest follow-up, i.e. we preferred a biochemically 
validated quit rate to self-reported abstinence, and preferred continuous or sustained 
abstinence to point prevalence abstinence. We used abstinence at 12-month follow-up in 
preference to abstinence at six-month follow-up. We counted participants lost to followup as 
continuing smokers.
Search methods for identification of studies
We searched the Tobacco Addiction Group trials register in December 2011. This 
specialised register is regularly updated by electronic searches of databases including 
CENTRAL (2011 Issue 4), MEDLINE (via OVID to update 20111104.ud), EMBASE (via 
Ovid to update 20111104.em), PsycINFO (via OVID to 2011 November week 4) and 
handsearching of conference abstracts. Searches for the register cover smoking cessation, 
nicotine dependence, nicotine addiction and tobacco use. To identify papers potentially 
relevant to this reivew we searched for (hospital and patient*) or hospitali* or inpatient* or 
admission* or admitted in the title or abstract. In addition, we searched CINAHL (EBSCO 
to March 2012, search strategy in Appendix 1). We searched the Centers for Disease Control 
Smoking and Health database for the original review but since it did not retrieve any 
additional studies we did not use it for the update. We asked individuals with expertise in the 
area of smoking cessation for details of conference abstracts and studies in press. We hand-
checked bibliographies of studies generated by the search for further studies.
Data collection and analysis
Identification of studies and data extraction—Three authors checked studies 
identified by the search strategies for relevance. Two authors extracted data independently. 
Disagreements were resolved by consensus. We noted reasons for the exclusion of studies. 
For each study we extracted the following data:
i. author(s) and year of publication,
ii. methods (country of origin, recruitment, randomization and participants),
iii. description of intervention(s) and control, including a designation of intensity for 
behavioural interventions (1–4),
iv. outcomes (length of follow-up, definition of abstinence, validation technique).
If necessary we contacted the original authors for clarification of data.
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We reported the following information about each trial in the Characteristics of included 
studies table:
• Country
• Reasons for hospitalisation or specialty of admission
• Criteria for recruitment (e.g. current smokers only or recent quitters) and whether 
selected according to willingness to make a quit attempt
• Method of randomization and adequacy of concealment
• Smoking behaviour and characteristics of participants
• Therapist types
• Description of experimental and control interventions and classification by length 
of in-hospital contact and post-discharge support
• Outcome measures (definition of abstinence used in review, use of biochemical 
validation), number of deaths.
Assessment of risk of bias in included studies—We judged risk of bias on the basis 
descriptions of the randomization and allocation concealment procedure, as this is the main 
source of bias which has been empirically associated with over-estimation of treatment 
effects (Schulz 1995). We also assessed whether the studies reported validation of self-
reported smoking cessation, and assessed the studies for attrition bias, including how they 
handled patients lost to follow-up, since these are possible sources of bias in smoking 
cessation studies. We also assessed the extent to which study populations consisted of 
current smokers and recent quitters.
Analysis of the data—We used statistical methods for pooling using a Mantel-Haenszel 
fixed-effect method, with 95% confidence intervals. This summary statistic replaced the 
Peto method (Yusuf 1985) used in earlier versions of this review, since the Mantel-Haenszel 
method is now recommended for Cochrane reviews (Higgins 2011). Differences in results 
using the two methods are small, and most likely to be apparent where numbers are 
unbalanced between groups, in which case the Peto method may give biased results. Where 
there was substantial heterogeneity between studies we explored possible reasons using 
sensitivity analyses or considered the impact of outliers. We express results as a risk ratio 
(intervention risks/control risks) for achieving abstinence from smoking together with the 
95% confidence interval for this estimate. To investigate statistical heterogeneity we used 
the I2 statistic, given by the formula [(Q - df)/Q] × 100%, where Q is the Chi2 statistic and 
df is its degrees of freedom (Higgins 2003). This describes the percentage of the variability 
in effect estimates that is due to heterogeneity rather than sampling error (chance). A value 
greater than 50% may be considered to indicate moderate to substantial heterogeneity.
We calculated quit rates based on the numbers of patients randomized to an intervention, 
excluding any deaths. Those who dropped out or were lost to follow-up were counted as 
continuing smokers. Most studies verified self-reported smoking status with a biochemical 
test. In these studies, self-reported nonsmokers who did not pass the verification procedure 
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were counted as smokers. We noted the number of deaths in Characteristics of included 
studies.
We analysed data according to our pre-determined classification of four levels of intensity 
(see Types of interventions, above). Where we included studies that were judged to be more 
prone to bias, we planned sensitivity analyses to assess whether their inclusion altered our 
findings. We also planned sensitivity analyses to explore, where possible, the contribution of 
different components to an overall effect (for example, the role of NRT in a multicomponent 
intervention) and to determine whether the effects were different when the study population 
was restricted to those wishing to stop. Another sensitivity analysis explored the efficacy of 
interventions that differed only after hospital discharge. In these studies participants 
received an identical intervention in the hospital and were randomly assigned to different 
post-discharge treatments.
In an exploratory analysis, we evaluated the effects of interventions in patients admitted to 
hospital because of the following diagnoses: cardiovascular disease, respiratory disease and 
cancer. We also assessed the effects of interventions that were designed to be delivered to all 
(or nearly all) of the smokers who were admitted to hospital regardless of the smoker's 
admitting diagnosis. Where there were insufficient data for meta-analysis, the results were 
tabulated. In cases where a single study reported data on patients from different categories, 
we pooled the data only when it was possible to extract data by disease category. Otherwise 
we included only those studies reporting data from patients in a single disease category. A 
separate analysis included studies that met inclusion criteria but were conducted in 
rehabilitation hospitals rather than acute care hospitals. These studies were not included in 
the main analysis.
We include the Tobacco Addiction Group glossary of tobacco-specific terms (Appendix 2).
Results
Description of studies
Fifty trials conducted in the United States, the United Kingdom, Australia, Belgium, Brazil, 
Canada, Denmark, Germany, Israel, Japan, the Netherlands, Norway, and Spain between 
1990 and 2011 met the inclusion criteria and contributed to the review. The previous version 
of this review included 33 trials published between 1990 and 2007; this update includes 17 
new studies. All but 12 of the 50 studies contributed to the main comparison of a 
behavioural counselling intervention, classified by intensity, versus control. Eight that did 
not contribute (Campbell 1991; Campbell 1996; Ortega 2011; Rigotti 2006; Planer 2011; 
Simon 2009; Smith BJ 2011; Steinberg 2011) did not include a control group of usual care 
or less intensive counselling; the intervention tested in those studies was pharmacotherapy 
as an adjunct to behavioural support. Three studies that were performed in rehabilitation 
hospitals (Floter 2009; Haug 2011; Metz 2007) were also analysed separately from the 
studies conducted in acute care hospitals. Twenty-six studies (Bolman 2002; Borglykke 
2008; Campbell 1991; Campbell 1996; CASIS 1992; Chouinard 2005; Cossette 2011; 
Croghan 2005; DeBusk 1994; Dornelas 2000; Feeney 2001; Froelicher 2004; Hajek 2002; 
Miller 1997; Mohiuddin 2007; Ortigosa 2000; Pedersen 2005; Pederson 1991; Pelletier 
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1998; Planer 2011; Quist-Paulsen 2003; Reid 2003; Reid 2007; Rigotti 1994; Rigotti 2006; 
Smith 2009; Taylor 1990) provided separate data by disease and contributed to the 
comparison of intervention versus control in different disease categories. We describe each 
intervention in Characteristics of included studies. We excluded 66 studies which appeared 
relevant but did not meet all inclusion criteria (see Characteristics of excluded studies). We 
did not include two studies (Brunner-Frandsen 2010; Jimenez 2007) for which there was 
insufficient data to make a decision, despite our efforts to contact the authors for additional 
information; these remain in the Characteristics of studies awaiting classification.
Counselling interventions—Advice to quit smoking and/or behavioural counselling was 
provided in all 50 studies. In 48 of them, a nurse or counsellor provided stop-smoking 
advice and/or behavioural counselling. Twelve studies included physician advice to quit 
(Campbell 1991; Campbell 1996; Croghan 2005; DeBusk 1994; Feeney 2001; Froelicher 
2004; Hennrikus 2005; Lacasse 2008; Lewis 1998; Miller 1997; Ortigosa 2000; Pelletier 
1998;), and in one study physician advice was offered prior to admission (Pederson 1991). 
In three studies, the patient chart was stamped with a prompt to remind the physician to offer 
smoking cessation advice (Rigotti 1997; Smith 2009; Smith PM 2011). Counselling ranged 
in duration from less than five minutes to two hours. In nine studies, counselling was 
delivered on more than one occasion during the hospitalisation period (Borglykke 2008; 
CASIS 1992; Cossette 2011; Floter 2009; Metz 2007; Nagle 2005; Ortega 2011; Pederson 
1991; Rigotti 1994). Most studies also included materials such as self-help booklets, 
relaxation audio tapes and video tapes. In Haug 2011, participants were provided with 
access to an internet-based smoking cessation program and no face-to-face counselling was 
performed. In Smith BJ 2011, patients were referred to a quitline and were called by a 
quitline counsellor.
Forty-two of 50 studies (all except Bolman 2002; Croghan 2005; Hajek 2002; Hennrikus 
2005; Molyneux 2003; Nagle 2005; Pederson 1991; Pelletier 1998) offered follow-up 
support following discharge. Of these, 29 offered support by telephone (Caruthers 2006; 
CASIS 1992; Chouinard 2005; Cossette 2011; de Azevedo 2010; DeBusk 1994; Dornelas 
2000; Floter 2009 ; Froelicher 2004; Hasuo 2004; Hennrikus 2005; Lacasse 2008; Lewis 
1998; Metz 2007; Miller 1997; Ortigosa 2000; Quist-Paulsen 2003; Rigotti 1994; Rigotti 
1997; Rigotti 2006; Simon 1997; Simon 2003; Simon 2009; Smith 2009; Smith BJ 2011; 
Smith PM 2011; Stevens 1993; Stevens 2000; Taylor 1990), nine provided in-person support 
in various settings (Borglykke 2008; Campbell 1991; Campbell 1996; Meysman 2010; 
Mohiuddin 2007; Pedersen 2005; Reid 2003; Steinberg 2011; Vial 2002), and two offered 
support by telephone and/or in-person (Ortega 2011; Planer 2011). Two studies used newer 
technologies to contact patients after discharge: Haug 2011 provided individual feedback 
letters, an internet-based smoking cessation program and offered email support and Reid 
2007 used an Interactive Voice Response (IVR) system. The duration of extended support 
ranged from one week to 12 months from discharge.
Pharmacotherapy—No studies tested the efficacy of pharmacotherapy with nicotine 
replacement therapy (NRT), bupropion, or varenicline versus placebo in the absence of a 
counselling intervention. However, six studies tested the marginal value of adding NRT to a 
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counselling intervention (Campbell 1991; Campbell 1996; Lewis 1998; Molyneux 2003; 
Ortega 2011; Vial 2002), three studies tested the marginal value of adding bupropion to a 
counselling intervention (Planer 2011; Rigotti 2006; Simon 2009), and two trials tested the 
marginal value of adding varenicline to a counselling intervention (Smith BJ 2011; 
Steinberg 2011). One trial (Simon 2003) tested the marginal value of adding counselling to 
pharmacotherapy with NRT. In a number of other studies, particularly the newer ones, 
pharmacotherapy was allowed as part of the intervention or available to participants in the 
trial but was not specifically offered to all participants in one group and to none in another. 
Fourteen studies that reported providing NRT to a subgroup of patients did not specify the 
extent of its use (Borglykke 2008; Caruthers 2006; Chouinard 2005; DeBusk 1994; 
Froelicher 2004; Lacasse 2008; Pedersen 2005; Quist-Paulsen 2003; Reid 2003; Reid 2007; 
Rigotti 1997; Simon 1997; Simon 2003; Taylor 1990). Two studies included bupropion in a 
similar fashion (Chouinard 2005; Mohiuddin 2007) and in one study NRT, bupropion or 
varenicline were suggested during hospitalisation and follow-up (Cossette 2011).
Other study characteristics—Three studies compared two durations of post-discharge 
follow-up with a usual care control (Chouinard 2005; Hennrikus 2005; Miller 1997). Results 
from each arm of these studies were included separately in the analysis by intervention 
intensity. In four other studies that compared two intervention arms to a usual care control, 
the behavioural support offered in the two arms was comparable and results of the two 
intervention arms were combined in the analysis by intensity subgroups (Floter 2009; Lewis 
1998; Molyneux 2003; Vial 2002). In Lewis 1998 and Molyneux 2003, the two intervention 
arms differed by the presence or absence of nicotine replacement, and these arms were 
directly compared in the pooled analysis of the effect of NRT. In Vial 2002, both 
intervention arms included the use of NRT, and compared follow-up from either a hospital 
or community pharmacist. In Floter 2009, both intervention arms included group counselling 
sessions during hospitalisation and follow-up with proactive telephone calls but the post-
discharge intervention differed in style. In one study the smoking cessation intervention was 
part of a multicomponent risk intervention for patients with cardiovascular disease (DeBusk 
1994); in this case the smoking cessation intervention was well-defined and met our 
inclusion criteria. Two studies had a third arm consisting of control patients who were not 
assigned randomly (de Azevedo 2010; Ortega 2011). We excluded the nonrandomised 
patients from analyses of these studies.
Most studies (37 of 50) assessed cigarette abstinence 12 months after hospital discharge. 
Thirteen studies reported a shorter follow-up period of six months (Caruthers 2006; Cossette 
2011; Croghan 2005; de Azevedo 2010; Floter 2009; Haug 2011; Lewis 1998; Meysman 
2010; Pedersen 2005; Pederson 1991; Rigotti 1997; Simon 2009; Steinberg 2011). Fewer 
than half of the studies (20 of 50) used the preferred outcome measure, sustained abstinence. 
Twenty-eight studies used point prevalence abstinence as the outcome measure and two 
studies did not specify how abstinence was defined (Cossette 2011 ; Ortega 2011). One 
study reported sustained abstinence rates for overall cessation but point prevalence rates by 
diagnosis (Miller 1997).
All but two studies included both males and females; the exceptions (Floter 2009; Froelicher 
2004) included only females. All studies included adults who smoked cigarettes currently or 
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recently (e.g., within the past month). Seven studies included recent quitters as well as 
current smokers (CASIS 1992; DeBusk 1994; Haug 2011; Nagle 2005; Rigotti 1994; 
Stevens 1993; Stevens 2000).
Risk of bias in included studies
Fifteen of the fifty studies reported procedures for both random sequence generation and 
allocation concealment that we judged likely to avoid selection bias (Cossette 2011; de 
Azevedo 2010; DeBusk 1994; Froelicher 2004; Hajek 2002; Hasuo 2004; Lewis 1998; 
Nagle 2005; Reid 2003; Reid 2007; Rigotti 2006; Smith BJ 2011; Steinberg 2011; Taylor 
1990; Vial 2002). Seventeen studies did not report the method of randomization and 
concealment in enough detail to judge the risk of selection bias, nine studies had low risk of 
selection bias for random sequence generation but unclear risk for allocation concealment, 
and three studies had unclear risk for random sequence generation and low risk for 
allocation concealment. Six studies did not allocate treatment at the individual patient level 
(Borglykke 2008; Bolman 2002; Haug 2011; Pelletier 1998; Stevens 1993 ; Stevens 2000). 
Two of them allocated treatment by alternating the intervention condition between hospitals 
over time (Stevens 1993, Stevens 2000) and one study employed a quasi-experimental 
design with one intervention and two control hospitals (Pelletier 1998). One study used a 
quasi-experimental design and assigned participants to intervention or control group 
according to bed availability in two wards of the same hospital (Borglykke 2008) while 
another used a quasirandomized design where participants were assigned to control or 
intervention groups based on the calendar week of admission (Haug 2011). One other study 
(Bolman 2002) was not fully randomized; seven of 11 participating hospitals were 
randomized to condition, but four others selected their study arm. All six of these studies 
share the potential problems of recruitment bias and of underestimation of confidence limits 
due to intracluster correlation. Therefore, we conducted sensitivity analyses on the effect of 
excluding them.
The majority of studies (33 out of 50) reported numbers lost to follow-up and methods for 
addressing incomplete outcome data that we judged at low risk of attrition bias. Fourteen 
studies did not report enough information to be assessed for incomplete outcome data and 
were hence rated as unclear. Three studies were rated at high risk of attrition bias: Feeney 
2001 assessed only those participants who attended a follow-up programme and hence had a 
large and unequal percentage of losses to follow-up; in Metz 2007, sensitivity analysis 
excluding losses to follow-up removes the significance of the study findings due to 
differential drop-out rates between study arms; and differential drop-out rates in Taylor 1990 
increased the apparent effect of the intervention when using an intent-to-treat approach.
Most studies (41 of 50) used a method to validate subjects' self-reports of quitting at the 
follow-up assessment. Biochemical validation of smoking status was done in 32 studies, 
using expired air carbon monoxide in 15 studies (Campbell 1991; Campbell 1996; Caruthers 
2006; CASIS 1992; Croghan 2005; DeBusk 1994; Hajek 2002; Lewis 1998; Mohiuddin 
2007; Molyneux 2003; Ortigosa 2000; Reid 2003; Steinberg 2011; Taylor 1990; Vial 2002), 
and using plasma, salivary, or urinary cotinine in 17 studies (Chouinard 2005; DeBusk 1994; 
Feeney 2001; Froelicher 2004; Hajek 2002; Hasuo 2004; Hennrikus 2005; Lacasse 2008; 
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Miller 1997; Nagle 2005; Quist-Paulsen 2003; Rigotti 1994; Rigotti 1997; Rigotti 2006; 
Simon 1997; Simon 2003; Simon 2009). Two studies used "corroboration by significant 
other" as the only validation method (Dornelas 2000; Smith 2009), and five other studies 
used "corroboration by significant other" in cases where a plasma or salivary cotinine 
measure was not available (Froelicher 2004; Lewis 1998; Miller 1997; Simon 2003; Smith 
2009). Thirteen studies (Bolman 2002; Cossette 2011; de Azevedo 2010; Floter 2009; Haug 
2011; Metz 2007; Meysman 2010; Pedersen 2005; Pelletier 1998; Planer 2011; Reid 2007; 
Stevens 1993; Stevens 2000) did not validate self-reported quitting at the follow-up 
assessment for any participants. Five others (Borglykke 2008; Ortega 2011; Pederson 1991; 
Reid 2003; Vial 2002) did not validate the smoking status of all participants who self-
reported abstinence. Four studies used more than one means of validation other than 
corroboration by significant other (Chouinard 2005; DeBusk 1994; Rigotti 2006; Taylor 
1990). In one study (Smith BJ 2011), validation of smoking abstinence with expired air 
carbon monoxide was performed only in a subsample but we used self-reported smoking 
abstinence rates in the analyses.
Most studies recruited participants on the basis of a convenience sample, with randomization 
being to group (intervention or control) rather than to initial inclusion. Participation rates 
(i.e., the proportion of those approached who agreed to take part in the trial) were also 
seldom recorded. Most studies recorded those lost to follow-up as continuing smokers. In 
one study (Stevens 2000), the intervention was offered inconsistently, with only 68% of 
those eligible for the intervention actually being approached.
Effects of interventions
Effect of counselling interventions categorised by intensity Figure 1—Only one 
included study (Hennrikus 2005) reported on the effect of a brief intervention in hospitalised 
patients with no followup after discharge (intensity 1). That study had a large sample size 
(>650 subjects per study arm). The brief intervention was no more effective than usual care 
(RR 1.14, 95% CI 0.82 to 1.59) although the confidence limits did not exclude the 
possibility of a benefit. Nine studies (Bolman 2002; Chouinard 2005; Croghan 2005; Hajek 
2002; Meysman 2010; Molyneux 2003; Nagle 2005; Pederson 1991; Pelletier 1998) used a 
more intensive intervention in hospital but had no follow-up intervention component after 
discharge (intensity 2). There was no evidence of a significant benefit from pooling these 
studies and the confidence intervals suggest that any effect is likely to be small (RR 1.10, 
95% CI 0.96 to 1.25, I2 = 44%). Similar lack of statistically significant benefit was observed 
in a pooled analysis of the six studies that tested the effect of an intervention that began 
during hospitalisation and continued for up to 1 month after discharge (intensity 3). The risk 
ratio and confidence interval for the estimate of the effect of this level of intervention (RR 
1.07, 95% CI 0.93 to 1.24, I2 = 11%) is almost identical to that produced by the intensity 2 
intervention.
In this update, we added eight new included studies that tested the highest intensity 
intervention (intensity 4), consisting of counselling that began in the hospital and continued 
for more than one month after discharge. The pooled estimate showed a statistically 
significant increase in quit rates that was similar to the previous review (RR 1.37, 95% CI 
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1.27 to 1.48, 25 studies) and heterogeneity remained relatively low (I2 = 32%). This estimate 
excludes one study (Feeney 2001) which was an extreme outlier reporting a very large 
effect. In this trial amongst 198 patients admitted to a coronary care unit there was a very 
high drop out rate (79%) and low quit rate (1%) at 12 months in the usual care condition 
whilst the dropout rate was 55% and the quit rate 34% in the intervention group. The 
intervention group quit rate was comparable to that of other trials in the intensity 4 
subgroup, but control group quit rates in the other trials were typically over 10%. This 
suggested that the difference in relative effect might have been due to characteristics of the 
support given to the control group and we decided to exclude this trial from the meta-
analysis.
Three of the eight newly identified studies testing the most intensive intervention had a 
different design from the other trials (Caruthers 2006; Cossette 2011; Reid 2007). In these 
studies, all participants received the same intervention while in the hospital but were 
randomly assigned to interventions that differed after hospital discharge. We conducted a 
subgroup analysis limited to these trials in order to isolate the specific effect of a post-
discharge intervention. The pooled estimate was a statistically significant 51% increase in 
smoking cessation rates (RR 1.51, 95% CI 1.03 to 2.22, I2 = 44% Analysis 2.1) with the 
addition of a post-discharge counselling intervention.
The studies included in the preceding analyses were all conducted in acute care hospitals. 
We also identified three trials conducted in rehabilitation hospitals (Floter 2009; Haug 2011; 
Metz 2007), where patients are less acutely ill and length of stays are longer. Because of 
these differences, we chose to analyse studies from rehabilitation hospitals separately from 
studies in acute care hospitals. The interventions provided by studies based in the 
rehabilitation hospitals were of similar intensity; each provided over one month of follow-up 
contact after discharge (intensity 4), allowing us to pool the results. The pooled estimate was 
a statistically significant 71% increase in smoking cessation rates (RR 1.71, 95% CI 1.37 to 
2.14, I2 = 0% Analysis 3.1).
Sensitivity analyses—Some studies of behavioural counselling also included the option 
of pharmacotherapy, principally NRT. A sensitivity analysis excluding eighteen studies that 
reported the use of NRT within the highest intervention intensity did not suggest that the 
efficacy of these interventions was due to the use of NRT. The result from pooling only the 
seven trials that did not include the option of pharmacotherapy (CASIS 1992; de Azevedo 
2010; Dornelas 2000; Hasuo 2004; Hennrikus 2005; Smith 2009; Smith PM 2011) though 
smaller, remained statistically significant (RR 1.24, 95% CI 1.09 to 1.41, I2 = 0%).
Another sensitivity analysis excluded studies that did not randomly assign subjects to 
condition. Within studies that did not provide follow-up (intensity 2) we performed a 
sensitivity analysis excluding data reported by two studies that did not fully randomise 
patients (Bolman 2002; Pelletier 1998). The conclusion did not change (RR 1.03, 95% CI 
0.87 to 1.22, I2 = 44%). Within the group of studies that delivered an intervention with 
minimal follow-up (intensity 3) a sensitivity analysis excluding the data reported by two 
studies that did not randomise patients (Stevens 1993, Stevens 2000) slightly modified the 
point estimate, but did not substantially affect the confidence intervals (RR 1.01, 95% CI 
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0.83 to 1.21, I2 = 0%). Within the group of studies with highest level of intensity of 
intervention (intensity 4), a sensitivity analysis excluding the data from one study that used a 
quasi-experimental design (Borglykke 2008) did not change the effect estimate (RR 1.35, 
95% CI 1.25 to 1.46, I2= 28%).
Approximately half of the studies that delivered the highest intervention intensity (intensity 
4) excluded smokers who were not willing to attempt cessation after discharge. We 
performed a sensitivity analysis excluding the data reported by 13 studies in which 
participants were selected on the basis of their willingness to make a quit attempt (Caruthers 
2006; Cossette 2011; DeBusk 1994; Froelicher 2004; Hasuo 2004; Lacasse 2008; Lewis 
1998; Miller 1997; Reid 2003; Simon 1997; Smith PM 2011; Taylor 1990; Vial 2002). An 
intervention effect persisted in the remaining 12 studies (RR 1.44, 95% CI 1.28 to 1.62, I2 = 
43%).
We performed a sensitivity analysis excluding studies that enrolled former smokers (defined 
as having not smoked for more than one month before admission) as well as current smokers 
(CASIS 1992; DeBusk 1994; Nagle 2005; Rigotti 1994; Stevens 1993; Stevens 2000, Taylor 
1990;). For intensity 3 (studies delivering a minimal intensity intervention with short-term 
follow-up), limiting the analysis to current smokers produced little change in the result (RR 
1.01, 95% CI 0.82 to 1.24, I2 = 0%). For studies delivering the highest intervention intensity 
(intensity 4), a statistically significant increase in quitting remained even after the exclusion 
of studies that included quitters, and the point estimate changed little (RR 1.35, 95% CI 1.24 
to 1.48, I2 = 35%). In the update, only one new study included both current smokers and 
recent former smokers who had quit for six months or less (Haug 2011), and this study was 
performed in a rehabilitation setting. Excluding this study from the analysis did not 
significantly change the estimate but only two studies remained in the analysis for 
rehabilitation centres (RR 1.56, 95% CI 1.20 to 2.03, I2 = 0%).
We performed a sensitivity analysis excluding 15 studies that did not validate self-reported 
smoking cessation outcomes (Bolman 2002; Borglykke 2008; Cossette 2011; de Azevedo 
2010; Floter 2009; Haug 2011; Metz 2007; Meysman 2010; Pedersen 2005; Pelletier 1998; 
Planer 2011; Reid 2007; Smith BJ 2011; Stevens 1993; Stevens 2000). This did not alter the 
results. The point estimates for the lower intensity interventions declined, but confidence 
intervals remained wide and conclusions did not change (intensity 2 RR 0.96, 95% CI 0.81 
to 1.14, I2 = 0%; intensity 3 RR 1.01, 95% CI 0.83 to 1.21, I2 = 0%). Five studies in the 
most intensive intervention category (intensity 4) did not validate self-reported smoking 
cessation (Borglykke 2008; Cossette 2011; de Azevedo 2010; Pedersen 2005; Reid 2007). 
Excluding them did not alter the point estimate or statistical significance of the effect (RR 
1.38, 95% CI 1.28 to 1.50, I2 = 32%).
Effect of pharmacotherapy—The effect of pharmacotherapy compared with placebo as 
a single intervention in the absence of counselling has not been tested. Several trials have 
tested the effect of adding pharmacotherapy to a counselling intervention or, conversely, of 
adding counselling to a pharmacotherapy intervention.
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NRT: Six trials (Campbell 1991, Campbell 1996, Lewis 1998; Molyneux 2003; Ortega 
2011; Vial 2002) tested the marginal effect of NRT added to counselling. In these trials, 
NRT was compared with placebo NRT or no NRT and all subjects received a counselling 
intervention. Pooled analysis of these studies produced a significant RR of 1.54 (95% CI 
1.34 to 1.79, I2 = 33%, Analysis 4.1.1). This result is consistent with the effect of NRT seen 
in other settings (Stead 2008b). One trial compared the effect of adding intensive 
counselling versus minimal counselling to an NRT intervention (Simon 2003). The study 
had an RR of 1.68 for sustained abstinence, but the confidence limits of that estimate missed 
statistical significance (95% CI 0.80, 3.53). However, the result was consistent with the 
impact of intensive counselling observed in the absence of pharmacotherapy.
Bupropion: Three studies systematically compared the use of bupropion with placebo 
among hospitalised smokers who also received intensive smoking cessation counselling 
(Planer 2011; Rigotti 2006; Simon 2009). The pooled analysis did not detect a statistically 
significant effect of the drug over intensive counselling alone (RR 1.04, 95% CI 0.75 to 
1.45, I2 = 29%, Analysis 4.1.2). While the confidence limits were wide, they do not 
encompass the confidence limits for the effect of bupropion in other settings (OR 1.94, 95% 
CI 1.72 to 2.19, Hughes 2007), suggesting that bupropion may not be effective, or may be 
less effective, when started in the hospital.
Varenicline: Two studies of varenicline compared the use of varenicline with placebo 
(Steinberg 2011) or counselling alone (Smith BJ 2011). The pooled estimate suggested an 
effect of the drug over intensive counselling alone (RR 1.29, 95% CI 0.95 to 1.76) but the 
wide confidence limits reflect the small numbers of participants (580) and the result was not 
statistically significant. There was also heterogeneity between the two studies (I2= 62%), 
with Steinberg 2011 reporting lower quit rates in the varenicline group.
Effect of intervention by diagnosis—The included studies were heterogeneous in the 
types of hospitalised patients who were recruited. Because of this diagnostic heterogeneity, 
we examined the results of interventions within the following diagnostic groups, keeping the 
same intensity subgroups where the number of studies justified this approach. Seventeen 
studies enrolled hospital patients with a wide range of admitting diagnoses. These studies 
tested smoking intervention programs that were implemented hospital-wide (Caruthers 
2006; de Azevedo 2010; Hasuo 2004; Hennrikus 2005; Lewis 1998; Miller 1997; Molyneux 
2003; Nagle 2005; Rigotti 1997; Simon 2003; Simon 2009; Smith BJ 2011; Smith PM 2011; 
Steinberg 2011; Stevens 1993; Stevens 2000; Vial 2002). Twenty-two studies reported on 
the effects of interventions in patients hospitalised with a cardiovascular diagnosis (Bolman 
2002; Campbell 1991; CASIS 1992; Chouinard 2005; Cossette 2011; DeBusk 1994; 
Dornelas 2000; Froelicher 2004 ; Hajek 2002; Miller 1997; Mohiuddin 2007; Ortigosa 2000; 
Pedersen 2005; Pelletier 1998; Planer 2011; Quist-Paulsen 2003; Reid 2003; Reid 2007; 
Rigotti 1994; Rigotti 2006; Simon 2009; Taylor 1990). Five studies reported on 
interventions in patients with a respiratory diagnosis (Borglykke 2008; Campbell 
1991;Campbell 1996; Miller 1997; Pederson 1991). Only one small pilot study was found 
that recruited hospitalised patients admitted for a cancer diagnosis (Croghan 2005).
Rigotti et al. Page 14
Cochrane Database Syst Rev. Author manuscript; available in PMC 2015 July 10.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
The pattern of effect across intervention intensities was similar for the eighteen studies that 
enrolled patients with all admitting diagnoses (Analysis 5.1). Interventions categorized as 
intensity 4 were effective in a pooled analysis of twelve studies in this subgroup (RR 1.26, 
95% CI 1.12 to 1.42, I2 = 25%). The risk ratio was lower than the effect of the intensity 4 
intervention in the overall analysis, but the confidence intervals overlap and we cannot 
conclude that intensive interventions are less effective in this subgroup. Pooled analysis of 
less intensive interventions demonstrated no effect and did not differ from the overall 
analysis (intensity 2: RR 0.90, 95% CI 0.64 to 1.28, I2 = 0%, 2 studies; intensity 3, RR 1.10, 
95% CI 0.94 to 1.29, I2 = 28%, 4 studies).
The estimate of the effect for each level of intervention intensity among patients with a 
cardiovascular diagnosis was also very similar to that for the entire sample of hospitalised 
patients (Analysis 5.2). Pooled analysis of 14 studies reporting on the effect of the most 
intensive intervention (intensity 4) found a statistically significant effect (RR 1.42, 95% CI 
1.29 to 1.56, I2 = 32%, CASIS 1992; Chouinard 2005; Cossette 2011; DeBusk 1994; 
Dornelas 2000; Froelicher 2004; Miller 1997; Mohiuddin 2007; Pedersen 2005; Quist-
Paulsen 2003; Reid 2003; Reid 2007; Smith 2009; Taylor 1990). The point estimate of the 
effect was similar to that for overall analysis (RR 1.37, 95% CI 1.27 to 1.48), the confidence 
intervals overlap substantially, and we cannot conclude that interventions in patients 
hospitalised for cardiovascular disease are more effective than in the general hospital 
population. No statistically significant effect was found for interventions of lower intensity. 
Pooled analysis of four studies of in-hospital counselling without follow-up after discharge 
(intensity 2) found no intervention effect (RR 1.10, 95% CI 0.94 to 1.28, I2 = 58%, Bolman 
2002; Chouinard 2005; Hajek 2002; Pelletier 1998). Pooled analysis of three studies that 
provided in-hospital counselling and brief follow-up contact after discharge (intensity 3) 
also found no intervention effect (RR 1.04, 95% CI 0.84 to 1.28, I2 = 0%, Miller 1997; 
Ortigosa 2000; Rigotti 1994).
One of the trials that tested an intensity 4 smoking intervention in the cardiovascular 
subgroup (Mohiuddin 2007) also assessed all-cause mortality and hospital readmission rates 
as endpoints. Over a two-year follow-up, the intervention produced a relative risk reduction 
of 0.77 (95% CI 0.27 to 0.93, p=.014) in all-cause mortality and a relative risk reduction of 
0.44 (95% CI 0.16 to 0.63, p=.007) in hospital readmissions.
Five studies provided interventions to patients hospitalised with a respiratory diagnosis. Two 
of these studies evaluated NRT (Campbell 1991; Campbell 1996) and three other studies of 
counselling interventions used different intensity interventions (Borglykke 2008; Miller 
1997; Pederson 1991). We estimated a separate pooled effect for the NRT studies (RR 1.29, 
95% CI 0.62 to 2.69, I2 = 65%) and for the counselling studies (RR 1.22, 95% CI 0.93 to 
1.60, I2 = 76%).
One pilot study reported on the effects of a hospital-based intervention for patients with 
cancer (Croghan 2005). It found no evidence of efficacy but the sample size was very small 
and the confidence limits were very broad.
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Discussion
The results of this review indicate that smoking cessation counselling interventions 
delivered during a period of hospitalisation and including follow-up support that lasts at 
least one month after discharge increase smoking cessation rates. The estimated effect of 
such interventions was to increase the smoking cessation rate by 37% at six to 12 months 
after hospital discharge. This finding was robust. It remained statistically significant in 
sensitivity analyses that excluded studies of lower quality (e.g., those that did not validate 
self-reported smoking cessation at outcome or those that were not randomized). Neither the 
exclusion of studies that included recent quitters as well as current smokers nor those that 
included patients selected for motivation significantly affected the relative effect of 
intervention over control. This review found no evidence to support the efficacy of less 
intensive counselling interventions, such as those delivered only during hospitalisation or 
those which include less than one month of follow-up support after discharge. Therefore, 
post-discharge follow-up support appears to be an important component of interventions that 
begin during hospitalisation. We caution that the effect sizes observed in all these studies 
may be artificially modest because in many cases the "control" condition was more intensive 
than usual care or simply brief advice.
The counselling intervention in these studies was generally delivered by a research nurse or 
trained smoking cessation counsellor, not by a nurse responsible for other aspects of the 
patients' clinical care. Physician advice was a component of the intervention in many trials. 
There is no specific evidence from this review that brief physician advice to quit is effective 
by itself in the hospital setting, although evidence from trials in primary care settings 
support the efficacy of physician advice to quit (Stead 2008a). Pharmacotherapy with 
nicotine replacement therapy (NRT), bupropion, or varenicline was included in some of the 
counselling studies, especially the more recent ones. In most of these trials, the 
pharmacotherapy was not systematically provided to all subjects in the intervention arm or 
excluded from all subjects in the control arm. The efficacy of counselling interventions 
remained after excluding those studies that reported the use of NRT, suggesting that 
counselling alone is effective.
This update includes a new finding regarding pharmacotherapy. In hospitalised smokers the 
effect of pharmacotherapy by itself, compared to placebo or no pharmacotherapy in the 
absence of counselling, cannot be determined because no such trials have been conducted. 
However, the marginal effect of NRT, bupropion, or varenicline when added to counselling 
in the hospital setting has been tested. Pooled analysis of six studies found a statistically 
significant 54% increase in the smoking cessation rate when NRT was added to counselling 
alone. This finding is new since the 2007 update, at which time there was a non-significant 
trend toward finding the addition of NRT to counselling to be efficacious in the hospital 
setting. The current estimate of the effect of NRT in the hospital setting is within the 
confidence intervals of the estimated RRs from the Cochrane review of NRT: 1.43 (95% CI 
1.33 to 1.53) for nicotine gum and 1.66 (95% CI 1.53 to 1.81) for nicotine patch (Stead 
2008b). Hence these data support NRT's usefulness in appropriate patients during and 
following hospitalisation. Starting NRT before discharge was associated with a higher rate 
of NRT use two weeks after discharge in a non-randomized observational trial in one 
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hospital (Regan 2011). The marginal effect of counselling when added to NRT begun in the 
hospital was tested in only one study (Simon 2003). Intensive counselling increased the rate 
of smoking cessation over that achieved by NRT alone, but the result was not statistically 
significant (RR 1.68,95% CI 0.80, 3.53). However, the result was consistent with the pooled 
estimate from this review of the effect of intensive counselling without pharmacotherapy.
Fewer data are available to assess the benefit of bupropion or varenicline as adjuncts to 
smoking cessation counselling that starts in the hospital setting. This update identified two 
new trials of bupropion to add to one previous trial (Rigotti 2006). All three trials tested the 
marginal efficacy of bupropion over placebo among smokers who all received intensive 
counselling in the hospital setting. Bupropion was not more effective than placebo in the 
pooled analysis (RR 1.06, 95% CI 0.68 to 1.63). This finding contrasts with evidence that 
bupropion is effective for smoking cessation in other populations (Hughes 2007). A possible 
explanation for the lack of efficacy of bupropion in the context of hospitalisation is the long 
half-life of sustained-release bupropion. Steady-state bupropion blood levels occur only after 
five to seven days of drug administration. This is generally after hospital discharge. 
Consequently, hospitalised smokers may be discharged into an environment filled with cues 
to smoke before they have sufficient levels of bupropion for it to be effective.
This update also identified the first randomized controlled trials that tested the efficacy of 
initiating varenicline in the hospital setting. Two trials compared the efficacy of adding 
varenicline (versus placebo or no drug) to counselling in the hospital setting. The pooled 
result of these studies produced an estimated 28% increase in the rate of smoking cessation 
with varenicline, but the result was not statistically significant and confidence intervals were 
wide due to the small sample sizes of the trials (95% CI 0.88 to 2.26). This contrasts with 
strong evidence of efficacy and a higher estimate of the effect size of varenicline that has 
been found in a systematic review of varenicline (RR 2.27, 95% CI 2.02 to 2.55, Cahill 
2012).
The analyses by diagnosis demonstrate that the intensive counselling intervention is 
effective in the subgroup of patients admitted to hospital with a cardiovascular diagnosis, as 
it is for the overall group of hospitalised smokers who are not selected by diagnosis. The 
absolute cessation rates amongst smokers admitted with cardiovascular disease tended to be 
higher than amongst smokers not selected by diagnosis, but the relative effect of an intensive 
counselling intervention was not significantly greater in CVD patients. The potential benefit 
of intensive intervention in smokers with CVD was illustrated in the one study that assessed 
health care utilization and mortality outcomes (Mohiuddin 2007). That study found a large 
increase in smoking cessation in the intervention group, and at two-year follow-up, a 
substantial decline in hospital readmission and all-cause mortality rates. There was a 
possibility of confounding due to better control of blood pressure and cholesterol and better 
medication compliance in the intervention group. Among smokers hospitalised for 
myocardial infarction, intensive counselling begun in the hospital is highly cost effective, 
even when the cost of a course of pharmacotherapy is included in the calculation (Ladapo 
2011). The effectiveness of smoking cessation interventions for patients who are admitted to 
hospital with a respiratory diagnosis is less clear, in part because of a small number of 
studies in this subgroup. Overall, there is no strong evidence for a differential effect of the 
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intensive counselling intervention by diagnosis. These data support offering hospital-based 
interventions to all smokers, regardless of admitting diagnosis.
Determining how to translate these findings effectively and consistently into routine clinical 
practice is the next challenge for this field. The intervention in most of the trials included in 
this review was delivered by research staff. The effectiveness of implementing the 
intervention in routine clinical practice, where interventions will be delivered by clinical 
staff, needs to be demonstrated. Feasible models that can be readily implemented in hospital 
settings are needed. Current evidence on this point is limited. Two studies included in this 
review illustrate this challenge (Stevens 1993; Stevens 2000). Both studies provided a 
similar counselling intervention in a similar setting, but counselling was delivered by 
research staff (masters-level psychologists) in the first study and by clinical staff (trained 
respiratory therapists) in the second study. The intervention efficacy was demonstrated in 
the first study but did not persist in the second study. The feasibility of maintaining an 
efficacious intervention after the conclusion of a research trial was investigated for another 
study included in this systematic review (Miller 1997). The counselling intervention was 
maintained in the same hospitals for three years after the clinical trial ended. During that 
time approximately half of the smokers accepted the offer of intervention, and those 
smokers had a cessation rate comparable to that achieved in the randomized trial. These 
results suggested that programme effectiveness was maintained (Smith 2002). More studies 
are needed to demonstrate the feasibility and effectiveness of hospital-initiated smoking 
cessation interventions in routine practice.
Finally, this update includes the first studies conducted in rehabilitation hospitals. The 
results of the pooled analysis finds that smoking interventions in these settings are effective 
and extend the effect from acute care hospitals to a broader group of settings.
Authors' conclusions
Implications for practice
The results support the use of smoking cessation counselling interventions that begin during 
the hospitalisation period and include at least one month of follow-up supportive contact 
after discharge. There is no evidence that less intensive counselling interventions, 
particularly those that do not continue after hospital discharge, are effective in promoting 
smoking cessation. The efficacy of the counselling intervention does not clearly vary by a 
smoker's admitting diagnosis, and it is appropriate to offer the intervention to hospitalised 
smokers regardless of their admitting diagnosis. Adding nicotine replacement therapy to an 
intensive counselling intervention further increases the efficacy of hospital-initiated 
interventions and should be routinely offered. There is insufficient evidence regarding the 
benefit of adding varenicline or bupropion to counselling, although there was a trend toward 
statistical significance for varenicline and the results are compatible with data which show 
the effectiveness of varenicline in other settings. Bupropion may not be effective when 
added to counselling started in the hospital.
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Implications for research
The impact of an intensive counselling intervention that continues after hospital discharge is 
well-established. The efficacy of adding NRT to a counselling intervention in hospitalised 
patients is now also established, with a relative risk estimate that is consistent with the 
established efficacy of NRT. Further studies testing the efficacy of adding varenicline to 
counselling are warranted in view of the results of early studies. They might generate 
sufficient data to produce a statistically significant result in future pooled analyses. The 
pooled evidence of studies with bupropion does not provide support for further studies of the 
drug in this context.
Research is needed to identify effective strategies for implementing and disseminating this 
evidence into routine practice in health care systems.
Additional research is needed to assess the cost-effectiveness of the intensive counselling 
intervention and to explore the impact of counselling on health and healthcare utilization 
outcomes.
Supplementary Material
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Appendices
1 Details of search strategies for Tobacco Addiction register and CINAHL
Search strategy for the Tobacco Addiction specialised register: (hospital and patient*) or 
hospitali* or inpatient* or admission* or admitted
Search strategy for CINAHL (EBSCO):
S14 S4 and S5 and S13
S13 S6 or S7 or S8 or S9 or S10 or S11 or S12
S12 MH Placebos
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S11 TX RCT
S10 MH (Random assignment OR Clinical Trials+ OR Quantitative Studies)
S9 TX "control group*"
S8 TX "treatment arm"
S7 TX (trial and (control* OR comparative))
S6 TX (random* OR factorial* OR placebo* OR assign* OR allocat*
S5 MJ (smok* OR tobacco OR nicotine)
S4 S1 or S2 or S3
S3 MJ (hospitali* OR inpatient*)
S2 TI (hospitali* OR inpatient* OR admission* OR admitted) or AB (hospitali* OR inpatient* OR admission* OR 
admitted)
S1 TI (hospital with patient*) or AB (hospital with patient*)
2 Glossary of tobacco-specific terms
Abstinence A period of being quit, i.e. stopping the use of cigarettes or other 
tobacco products, May be defined in various ways; see also: point 
prevalence abstinence; prolonged abstinence; continuous/
sustained abstinence
Biochemical 
verification
Also called 'biochemical validation' or 'biochemical confirmation': 
A procedure for checking a tobacco user's report that he or she has 
not smoked or used tobacco. It can be measured by testing levels 
of nicotine or cotinine or other chemicals in blood, urine, or 
saliva, or by measuring levels of carbon monoxide in exhaled 
breath or in blood.
Bupropion A pharmaceutical drug originally developed as an antidepressant, 
but now also licensed for smoking cessation; trade names Zyban, 
Wellbutrin (when prescribed as an antidepressant)
Carbon monoxide 
(CO)
A colourless, odourless highly poisonous gas found in tobacco 
smoke and in the lungs of people who have recently smoked, or 
(in smaller amounts) in people who have been exposed to tobacco 
smoke. May be used for biochemical verification of abstinence.
Cessation Also called 'quitting' The goal of treatment to help people achieve 
abstinence from smoking or other tobacco use, also used to 
describe the process of changing the behaviour
Continuous 
abstinence
Also called 'sustained abstinence' A measure of cessation often 
used in clinical trials involving avoidance of all tobacco use since 
the quit day until the time the assessment is made. The definition 
occasionally allows for lapses. This is the most rigorous measure 
of abstinence
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Cold Turkey' Quitting abruptly, and/or quitting without behavioural or 
pharmaceutical support.
Craving A very intense urge or desire [to smoke]. See: Shiffman et al 
'Recommendations for the assessment of tobacco craving and 
withdrawal in smoking cessation trials' Nicotine & Tobacco 
Research 2004: 6(4): 599–614
Dopamine A neurotransmitter in the brain which regulates mood, attention, 
pleasure, reward, motivation and movement
Efficacy Also called 'treatment effect' or 'effect size': The difference in 
outcome between the experimental and control groups
Harm reduction Strategies to reduce harm caused by continued tobacco/nicotine 
use, such as reducing the number of cigarettes smoked, or 
switching to different brands or products, e.g. potentially reduced 
exposure products (PREPs), smokeless tobacco.
Lapse/slip Terms sometimes used for a return to tobacco use after a period of 
abstinence. A lapse or slip might be defined as a puff or two on a 
cigarette. This may proceed to relapse, or abstinence may be 
regained. Some definitions of continuous, sustained or prolonged 
abstinence require complete abstinence, but some allow for a 
limited number or duration of slips. People who lapse are very 
likely to relapse, but some treatments may have their effect by 
helping people recover from a lapse.
nAChR [neural nicotinic acetylcholine receptors]: Areas in the brain 
which are thought to respond to nicotine, forming the basis of 
nicotine addiction by stimulating the overflow of dopamine
Nicotine An alkaloid derived from tobacco, responsible for the 
psychoactive and addictive effects of smoking.
Nicotine 
Replacement 
Therapy (NRT)
A smoking cessation treatment in which nicotine from tobacco is 
replaced for a limited period by pharmaceutical nicotine. This 
reduces the craving and withdrawal experienced during the initial 
period of abstinence while users are learning to be tobacco-free 
The nicotine dose can be taken through the skin, using patches, by 
inhaling a spray, or by mouth using gum or lozenges.
Outcome Often used to describe the result being measured in trials that is of 
relevance to the review. For example smoking cessation is the 
outcome used in reviews of ways to help smokers quit. The exact 
outcome in terms of the definition of abstinence and the length of 
time that has elapsed since the quit attempt was made may vary 
from trial to trial.
Pharmacotherapy A treatment using pharmaceutical drugs, e.g. NRT, bupropion
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Point prevalence 
abstinence (PPA)
A measure of cessation based on behaviour at a particular point in 
time, or during a relatively brief specified period, e.g. 24 hours, 7 
days. It may include a mixture of recent and long-term quitters. cf. 
prolonged abstinence, continuous abstinence
Prolonged 
abstinence
A measure of cessation which typically allows a 'grace period' 
following the quit date (usually of about two weeks), to allow for 
slips/lapses during the first few days when the effect of treatment 
may still be emerging. See: Hughes et al 'Measures of abstinence 
in clinical trials: issues and recommendations'; Nicotine & 
Tobacco Research, 2003: 5 (1); 13–25
Relapse A return to regular smoking after a period of abstinence
Secondhand smoke Also called passive smoking or environmental tobacco smoke 
[ETS] A mixture of smoke exhaled by smokers and smoke 
released from smouldering cigarettes, cigars, pipes, bidis, etc. The 
smoke mixture contains gases and particulates, including nicotine, 
carcinogens and toxins.
Self-efficacy The belief that one will be able to change one's behaviour, e.g. to 
quit smoking
SPC [Summary of 
Product 
Characteristics]
Advice from the manufacturers of a drug, agreed with the relevant 
licensing authority, to enable health professionals to prescribe and 
use the treatment safely and effectively.
Tapering A gradual decrease in dose at the end of treatment, as an 
alternative to abruptly stopping treatment
Titration A technique of dosing at low levels at the beginning of treatment, 
and gradually increasing to full dose over a few days, to allow the 
body to get used to the drug. It is designed to limit side effects.
Withdrawal A variety of behavioural, affective, cognitive and physiological 
symptoms, usually transient, which occur after use of an addictive 
drug is reduced or stopped. See: Shiffman et al 'Recommendations 
for the assessment of tobacco craving and withdrawal in smoking 
cessation trials' Nicotine & Tobacco Research 2004: 6(4): 599–
614
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Figure 1. 
Forest plot of comparison: 1 Intervention v Control, by intensity of counselling intervention, 
outcome: 1.1 Quit at longest follow-up (6+ months).
Rigotti et al. Page 33
Cochrane Database Syst Rev. Author manuscript; available in PMC 2015 July 10.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 2. 
1 - Intervention v Control, by intensity of counselling intervention
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Figure 3. 
2 - Intervention v Control, trials with post discharge intervention
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Figure 4. 
3 - Intervention v Control, trials in rehabilitation centers
Rigotti et al. Page 36
Cochrane Database Syst Rev. Author manuscript; available in PMC 2015 July 10.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 5. 
4 - Intervention v Control, trials of pharmacotherapy (pharmacotherapy systematically 
varied by group)
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Figure 6. 
5 - Intervention v Control, by intervention intensity within diagnostic subgroups
Rigotti et al. Page 40
Cochrane Database Syst Rev. Author manuscript; available in PMC 2015 July 10.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Rigotti et al. Page 41
Characteristics of studies
Characteristics of included studies
Bolman 2002
Methods Country: Netherlands
Recruitment: Cardiac ward patients in 11 hospitals
Selection: All eligible patients asked to participate by ward nurses
Participants Participants: 789 smokers who had smoked in previous week
Number smoked: not stated
Age: 56 yrs average
Therapists: Physician, nurse
Interventions 1 Intervention (5 hospitals): Cardiologist advice, 15–30 min counselling from ward nurse. follow-up: 
Cardiologist prompted to advise at 4–6 wk clinic but no counselling provided by team. Self-help materials. 
No pharmacotherapy. [Intensity 2]
2 Control: Usual care
NRT: No
Outcomes Abstinence: Sustained at 12m
Validation: None
Died: 25 at 12m
Notes Included in CVD subcategory
Numbers in meta-analysis adjusted to approximate the OR reported from a logistic regression analysis on continuous 
abstinence (OR 1.17, 90% CI 0.85 to 1.61)
Risk of bias table
Bias Authors'
judgement
Support for judgement
Random sequence 
generation 
(selection bias)
High risk Cluster randomized by hospital, 4/11 self-selected intervention 
condition, although exclusion of these did not change results.
Allocation 
concealment 
(selection bias)
High risk Participants identified by ward nurses. Possibility of selection bias 
although control group nurses said to be blind to condition.
Incomplete outcome 
data (attrition bias)
Unclear risk 25 deaths, 38 refusals, 64 missing baseline data excluded from 
analysis denominator.
Borglykke 2008
Methods Country:Denmark
Recruitment: patients admitted with symptoms of acute exacerbation of COPD in 1 university hospital
Selection: all eligible patients asked to participate
Participants Participants: 223 current smokers
Diagnosis: COPD
Age: 65.9 yrs av.
Gender: 35% male
Willingness to quit: not reported
Therapists: nurses
Interventions 1 Intervention: smoking cessation groups: standard information on the benefits of smoking cessation, weekly 
sessions of 2 hours during 5 weeks. follow-up session at 3 month. [Intensity 4]
2 Control: usual care (not described)
Pharmacotherapy: complimentary NRT when needed in intervention group
Outcomes Abstinence: self-reported PP at 12m
Validation: CO (in 84% of patients)
Died: none reported
Notes Category: pulmonary patients
Only 48/105 intervention patients received intervention
OR adjusted for sex, age and duration of COPD: 2.83 (1.40–5.74)
Risk of bias table
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Bias Authors'
judgement
Support for judgement
Random sequence 
generation 
(selection bias)
High risk Not randomized. Participants assigned to intervention ward or control 
ward based on vacancy.
Allocation 
concealment 
(selection bias)
Low risk "On hospital admission, the patients were met by the medical officer 
in charge of the distribution of patients…who had no knowledge of 
the study being conducted. The medical officer randomly assigned the 
patients to one of the hospital wards by … vacancy."
Incomplete outcome 
data (attrition bias)
Low risk No loss to follow-up at 1 year.
Campbell 1991
Methods Country: UK
Recruitment: Inpatients with smoking-related diseases
Selected: Invited to participate
Participants Participants: 212 current smokers
Number smoked: not stated
Most had heart or lung disease
Therapists: Physician and non-specialist counsellor
Interventions 1 Intervention: Physician advice, inpatient counselling (1×, total not stated, type not stated). NRT (gum, dose 
2–4 mg, for 3m). follow-up (5× at 2, 3, 5 wks, 3m, 6m in clinic by counsellor)
2 Control: Other (as above, placebo NRT gum) [Intensity 4 for both arms]
NRT: Yes
Outcomes Abstinence: Sustained abstinence at 6 and 12m
Validation: Expired air CO
Died: None reported
Notes Not included in analysis by counselling intensity because arms differed only by use of NRT
Heart disease, lung disease and other given separately in analysis by diagnosis.
Risk of bias table
Bias Authors'
judgement
Support for judgement
Random sequence 
generation 
(selection bias)
Unclear risk "those who had agreed were given packages of identical appearance 
randomly containing either nicotine (2mg) or placebo gum"
Allocation 
concealment 
(selection bias)
Unclear risk No details reported
Incomplete outcome 
data (attrition bias)
Unclear risk "Non-attenders were classified as failures"; rate of drop-outs not 
reported.
Campbell 1996
Methods Country: UK
Recruitment: Inpatients with respiratory or cardiovascular disease
Selected: Prepared to make quit attempt
Participants Participants: 62 current smokers
Age: not stated
Approx. 75% had respiratory disease
Therapists: Physician and non-specialist counsellor
Interventions 1 Intervention: Physician advice. Counselling (1×, total 30–60 mins, type information). NRT (patch, dose 
17.5–35 mg, for 12 wks). follow-up (4× at 2, 4, 8, 12 wks in clinic by counsellor)
2 Control: Other (as above, placebo NRT patch) [Intensity 4 for both arms]
NRT: Yes
Outcomes Abstinence: Sustained abstinence at 3, 6, 12m
Validation: Expired air CO
Died: None reported
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Notes Only data on inpatients extracted from study. Included in respiratory disease subcategory.
Risk of bias table
Bias Authors'
judgement
Support for judgement
Random sequence 
generation 
(selection bias)
Unclear risk "randomized," method not described.
Allocation 
concealment 
(selection bias)
Unclear risk No details reported.
Incomplete outcome 
data (attrition bias)
Unclear risk ITT analysis, but number lost to follow-up in inpatient-only group not 
specified.
Caruthers 2006
Methods Country:USA
Recruitment: smokers admitted to a medical/surgical unit
Selection: A convenience sample of 80 participants of 106 individuals screened for participation
Participants Participants: 80 smokers (smoking at least one cigarette within 30 days of their hospital admission)
Diagnosis: med and surgical
Age: 51 yrs av.
Gender: 40% male
Willingness to quit: 79/80 indicated a desire to quit
Therapists: nurses
Interventions 1 Intervention: In-hospital counselling and study specific intervention booklet + post discharge phone calls (8 
individualized telephone calls in 12 weeks after discharge). [Intensity 4]
2 Control: enhanced usual care during hospitalisation
Pharmacotherapy: Smoking cessation pharmacotherapy was not provided as part of the intervention; however, several 
patients were prescribed such medication during their hospital admission.
Outcomes Abstinence: self-reported 7-day PP at 12 and 24 wks (6m) post-discharge
Validation: CO confirmed
Died: 3 (2 in intervention, 1 in control group)
Notes Additional information provided by 1st author 2/2012
Risk of bias table
Bias Authors'
judgement
Support for judgement
Random sequence 
generation 
(selection bias)
Low risk Adaptive randomization by minimization was computer generated via 
a program which provided stratification by gender, ethnicity, and 
whether the participant was admitted with or without tobacco related 
disorder(s)
Allocation 
concealment 
(selection bias)
Unclear risk not described
Incomplete outcome 
data (attrition bias)
Low risk 10 lost to follow-up in control group and 2 in intervention but ITT 
analyses conducted
CASIS 1992
Methods Country: USA
Recruitment: Inpatients with coronary artery stenosis confirmed by catheterization.
Selected: Invited to participate.
Participants Participants: 267 current smokers or recent quitters (50%, defined as at least 5 cpd at any time in previous 2m)
Number smoked: 25 cpd
Age: 53 yrs av.
78 had acute MI, 21 recent MI, 152 other symptoms
Therapists: Masters level health educators
Interventions 1 Intervention: Counselling (2×, total 40 mins, type not stated). Self-help materials, relaxation tapes. Follow-
up (4× at 1, 3 wks and 3m if quit or 2,4m if did not quit, by telephone) [Intensity 4]
2 Control: Advice only
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NRT: No
Outcomes Abstinence: Sustained abstinence at 6m, 12m
Validation: Expired air CO.
Died: None reported.
Notes Patients admitted with MI more likely to be quitters at 6m (74%). Evidence of interaction between intervention and 
illness.
Included in CVD subcategory
Risk of bias table
Bias Authors'
judgement
Support for judgement
Random sequence 
generation 
(selection bias)
Unclear risk Randomized, method not described
Allocation 
concealment 
(selection bias)
Unclear risk No details reported
Incomplete outcome 
data (attrition bias)
Unclear risk No mention of losses to follow-up. All survivors included in 
denominators.
Chouinard 2005
Methods Country: Canada
Recruitment: Inpatients with cardiovascular disease (MI, angina, CHF) or PVD
Selected: Not by motivation
Participants Participants: 168 past-month smokers
Number smoked: not stated
Age: 56 yrs av
Therapist: nurse
Interventions 1 Intervention 1: Counselling by research nurse (1×, 10–60 mins, av. 40 min, tailored to stage of change), 
23% used pharmacotherapy. [Intensity 2]
2 Intervention 2: As 1 plus telephone follow-up, 6 calls over 2m post-discharge [Intensity 4]
3 Control: cessation advice
NRT: Yes (partial)
Outcomes Abstinence: Sustained abstinence at 2 & 6m
Validation: Urine cotinine or expired air CO
Died: 3 in 1. 1 in 2. 0 in 3.
Notes Two interventions compared separately to control in intensity subgroups Included in CVD subcategory
Risk of bias table
Bias Authors'
judgement
Support for judgement
Random sequence 
generation 
(selection bias)
Low risk "Cluster randomization was used… by first randomly assigning 
individuals to predetermined clusters of three to six subjects. The 
group assignment was then randomly assigned to each of these 
clusters."
Allocation 
concealment 
(selection bias)
Unclear risk "Individuals not familiar with the study were in charge of the 
randomization procedure, which included inserting the information 
into envelopes that were sealed and would be opened by the 
investigator only at the time of treatment."
Comment: no other information on envelopes provided
Incomplete outcome 
data (attrition bias)
Low risk 4 deaths and 3 not meeting follow-up criteria excluded from meta-
analysis; all other dropouts and those lost to follow-up counted as 
smokers; similar numbers in all arms.
Cossette 2011
Methods Country:Canada
Recruitment: smokers admitted to 1 specialized cardiac hospital
Selection: all smokers who were hospitalised were asked to participate by the study nurse
Participants Participants: 40 current daily smokers
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Diagnosis: cardiovascular diseases
Age: 57.1 yrs av.
Gender: 60% male
Willingness to quit: yes (most in preparation stage, 1 in contemplation stage in control group)
Therapists: nurse specialized in smoking cessation
Interventions 1 Intervention:usual care during hospitalisation consisting of 1 or more sessions with the study nurse. 
Follow-up: 6 phone calls by study nurse at wk 1, 2, 3, 4, 8, 12 and then if needed additional phone calls 
could be arranged between 3 and 6m post discharge. At wk 3 appointment with the study nurse if asked by 
patient. [Intensity 4]
2 Control: usual care during hospitalisation consisting of 1 and more sessions with the study nurse. Follow-
up: referral to a national quitline or a community centre for smoking cessation
Pharmacotherapy: NRT, bupropion or varenicline were suggested during hospitalisation and follow-up
Outcomes Abstinence: self-reported abstinence at 6m
Validation: only for one participant
Died: 0
Notes Included in post-discharge intervention category (randomization after discharge)
Risk of bias table
Bias Authors'
judgement
Support for judgement
Random sequence 
generation 
(selection bias)
Low risk Not specified, but generated by a centre for randomized controlled 
trials
Allocation 
concealment 
(selection bias)
Low risk opaque sealed envelopes
Incomplete outcome 
data (attrition bias)
Low risk missing data similar in both groups and analyses are ITT, participants 
lost to follow-up considered smokers
Croghan 2005
Methods Country: USA
Recruitment: Inpatients having surgical resection of lung or oesophageal cancers
Selected: unclear
Participants Participants: 30 smokers admitted for surgery for newly diagnosed lung or oesophageal cancer
Age: not stated
Therapist: doctor, nurse and trained smoking counsellor
Interventions 1 Intervention: Physician advice from thoracic surgeons and study nurses. Counselling (1× 45 min. Stage of 
change assessed, individualized pharmacotherapy) [Intensity 2]
2 Control: Physician advice only
NRT: Yes
Outcomes Abstinence: 7-day PP at 6m
Validation: expired air CO or saliva tobacco alkaloid
Died: 1 in 6m
Notes
Risk of bias table
Bias Authors'
judgement
Support for judgement
Random sequence 
generation 
(selection bias)
Unclear risk Randomized, method not stated
Allocation 
concealment 
(selection bias)
Unclear risk No details reported
Incomplete outcome 
data (attrition bias)
Low risk 2 lost to follow-up in control group considered smokers. 1 death in 
intervention group excluded from MA.
de Azevedo 2010
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Methods Country:Brazil
Recruitment: patients admitted to 1 public university hospital
Selection: research team approached all patients admitted to the hospital wards (except for ICU and psychiatric unit)
Participants Participants: 273 current smokers (smoked ≥ 1 cpd in month prior to admission)
Diagnosis: all (exclude ICU and psychiatric units)
Age: not reported
Gender: 63.7% male
Willingness to quit: any
Therapists: trained smoking cessation counsellor (psychologists, nurses, occupational therapist)
Interventions 1 Intervention: 30 minutes session of individual counselling with motivational interview + 7 follow-up 
telephone calls over 4 months at wk 1, 2, 3 and month 1, 2, 3, 4. [Intensity 4]
2 Control: 15 minute session of individual counselling
Pharmacotherapy: none provided
Outcomes Abstinence:self-reported 7-day PP at 6m
Validation: none
Died: 28
Notes In the article, analyses excluded lost to follow-up and death.
Extra control arm not randomized and not included in data extraction.
Risk of bias table
Bias Authors'
judgement
Support for judgement
Random sequence 
generation 
(selection bias)
Low risk "An allocation sequence based on a random-number table was used to 
randomly assign all enrolled subjects"
Allocation 
concealment 
(selection bias)
Low risk "The allocation was maintained in a serially numbered, opaque 
envelope, which was opened at the Phase 2 interview to prevent 
counsellor bias."
Incomplete outcome 
data (attrition bias)
Low risk 32% lost to follow-up in intervention and 22% in control but if 
analysis are done ITT low risk of bias
DeBusk 1994
Methods Country: USA
Recruitment: Inpatients with acute MI
Selected: Invited to participate if prepared to make a quit attempt
Participants Participants: 252 current smokers or recent quitters (proportion not stated, defined as any tobacco use in previous 6m).
Number smoked: not stated
Age: 57 yrs av.
First year after MI
Therapists: Physician and nurse
Interventions 1 Intervention: Physician advice; Counselling (1×, total not stated, type not stated); NRT ('reserved for 
highly-addicted patients'); Other (self-help materials, relaxation tapes); follow-up (8× at 48 hr, 1 wk, and 
every month for 6m by telephone) [Intensity 4]
2 Control: Advice only
NRT: Yes (partial)
Outcomes Abstinence: Sustained abstinence at 6 and 12m
Validation: Expired air CO and plasma cotinine
Died: None reported
Notes Included in CVD subcategory
Risk of bias table
Bias Authors'
judgement
Support for judgement
Random sequence 
generation 
(selection bias)
Low risk "Patients were randomly assigned using a computer program that 
achieved a balanced allocation to the two management conditions 
within each hospital."
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Allocation 
concealment 
(selection bias)
Low risk "Randomization was done centrally; nurses were notified of the 
assignments by telephone calls from the coordinating centre staff."
Incomplete outcome 
data (attrition bias)
Unclear risk Unclear what percentage of smokers were lost to follow-up. "Among 
participants who did not relapse before death or dropout, censoring 
occurred at the last point at which they reported not smoking."
Dornelas 2000
Methods Country: USA
Recruitment: Inpatients with acute MI
Selected: Invited to participate
Participants Participants: 100 current smokers.
Number smoked: 29 cpd
Age: 54 yrs av.
Therapists: Psychologist
Interventions 1 Intervention: Counselling (1×, total 20 mins, type behavioural); follow-up (7× at <1, 4, 8, 12, 16, 20, 26 wk 
by telephone) [Intensity 4]
2 Control: Advice only
NRT: No
Outcomes Abstinence: PP at 12m
Validation: Significant other
Died: 5 at 12m
Notes Validation by significant other only in 70% of cases.
Included in CVD subcategory
Risk of bias table
Bias Authors' judgement Support for judgement
Random sequence 
generation 
(selection bias)
Unclear risk Method of sequence generation not specified
Allocation 
concealment 
(selection bias)
Unclear risk "drawing random numbers from an envelope"
Comment: no further details provided
Incomplete outcome 
data (attrition bias)
Low risk 20 (20%) lost to follow-up included in ITT analysis
Feeney 2001
Methods Country: Australia
Recruitment: Inpatients admitted for acute MI to coronary care unit of 1 hospital
Selected: Invited to participate
Participants Participants: 198 current smokers (smoked in past week)
Age: 54 yrs av.
Therapists: Physician and nurse
Interventions 1 Intervention: Physician advice to quit, nurse counselling (time not specified, type cognitive/behavioural); 
follow-up (8x at 1, 2, 3, 4 wks and 2, 3, 6,12m by telephone) [Intensity 4]
2 Control: In hospital: same as intervention (physician advice to quit, nurse counselling); follow-up 
counselling available but no proactive contact [Intensity 2]
NRT: No
Outcomes Abstinence: Sustained abstinence at 1, 3, 12m.
Validation: Urinary cotinine (limit not stated)
Died: 9 at 12m
Notes Very large treatment effect (31/92 vs 1/97) but risk of attrition bias. Excluded from meta-analyses because of 
heterogeneity.
Risk of bias table
Bias Authors'
judgement
Support for judgement
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Random sequence 
generation 
(selection bias)
Low risk "A random list of odd and even numbers was generated and a 
sequence of 200 sealed envelopes created."
Allocation 
concealment 
(selection bias)
Unclear risk "With patient consent an envelope was opened and they were 
assigned to either programme."
Comment: no other detail on envelopes provided.
Incomplete outcome 
data (attrition bias)
High risk Only participants who attended basic ADAU follow-up programme 
assessed, so large number of drop-outs. More drop-outs in group 2 
(79%) than group 1 (51%), so treating drop-outs as smokers may 
overestimate treatment effect. 9 deaths (4/5) excluded from 
denominator in analysis.
Floter 2009
Methods Country: Germany
Recruitment: women admitted in 21 prevention or rehabilitation clinics
Selection: all women who smoked were offered a smoking cessation course
Participants Participants: 527 smokers ≥ 1 cigarette during the 30 days preceding hospitalisation
Diagnosis: women hospitalised with their children for medical, psycho physiologic or psychiatric reasons
Age: 35.9
Gender: 100% female
Willingness to quit: all stages
Therapists: social workers, psychologists, physicians or nurses and counsellors
Interventions 1 Intervention: we pooled the 2 interventions
- Intervention 1: 3 sessions (60 min each) in groups during hospitalisation featuring cognitive 
behavioral therapy and motivational interviewing + 3 proactive telephone calls (10 min duration) 
post discharge in a structured and directive style
- Intervention 2: 3 sessions (60 min each) in groups during hospitalisation featuring cognitive 
behavioral therapy and motivational interviewing + 3 proactive telephone calls (10 min duration) 
post discharge in a non directive style
[Interventions 1 and 2: intensity 4]
2 Control: 3 sessions (60 min each) in groups during clinic hospitalisation and no follow-up
Pharmacotherapy: not reported
Outcomes Abstinence: self-reported abstinence during the past 30 days at 6m
Validation: none
Died: none reported
Notes Category: post discharge intervention and rehabilitation centre
OR adjusted for age, single mother (yes/no), education, weight concern, smoking dependence, self efficacy, depression, 
perceived social support:
- 2.0 (95% CI 1.1–3.8) for intervention 1
- 1.3 (95% CI 0.7–2.5) for intervention 2
Risk of bias table
Bias Authors'
judgement
Support for judgement
Random sequence 
generation 
(selection bias)
Unclear risk not described
Allocation 
concealment 
(selection bias)
Unclear risk not described
Incomplete outcome 
data (attrition bias)
Unclear risk According to the text there are 80 lost to follow-up and according to 
table 2 there are 53 lost to follow-up. Not specified in which group.
Froelicher 2004
Methods Country: USA
Recruitment: Inpatients with CVD or PVD admitted to 10 hospitals
Selected: Willing to make quit attempt
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Participants Participants: 277 current smokers or recent quitters (smoked in past month), willing to make serious quit attempt at 
discharge
Gender: All females
Number smoked: 20 cpd
Age: 61 yrs av.
Therapists: Physician and nurse
Interventions 1 Intervention: Physician advice to quit, nurse counselling (30–45 mins, type cognitive/behavioural and 
relapse prevention); follow-up (5× at 2, 7, 21, 28, 90 days by telephone (5–10 min/call) [Intensity 4]
2 Control: modified usual care (physician advice + booklet)
NRT: Patch or gum offered to selected women after discharge who had relapsed and wanted to try to quit 
(pharmacotherapy used by 20% of intervention and 23% of control group).
Outcomes Abstinence: 7-day PP at 12m
Validation: Saliva cotinine < 14 ng/ml OR family/friend verification
Died: 11 at 12m
Notes Included in CVD subcategory
Risk of bias table
Bias Authors'
judgement
Support for judgement
Random sequence 
generation 
(selection bias)
Low risk "Randomization was by random permuted blocks, stratified by 
hospital, with an equal chance of assignment to the usual-care group 
or the intervention group."
Allocation 
concealment 
(selection bias)
Low risk Centralized randomization
Incomplete outcome 
data (attrition bias)
Low risk 20 participants (13 intervention; 7 control) lost to follow-up included 
in meta-analysis as smokers. 11 deaths excluded from meta-analysis.
Hajek 2002
Methods Country: UK
Recruitment: Inpatients with acute MI
Selected: Invited to participate
Participants Participants: 540 current smokers.
Number smoked: 23 cpd
Age: 56 yrs av.
Therapists: cardiac rehab nurse
Interventions 1 Intervention: Nurse advice. Counselling (1×, total 20–30 min). Self-help materials. [Intensity 2]
2 Control: Brief advice and booklet
NRT: No
Outcomes Abstinence: PP at 12m, with visit to self-reported non-smoker
Validation: Expired air CO and salivary cotinine
Died: 35 at 12m
Notes Included in CVD subcategory
Risk of bias table
Bias Authors'
judgement
Support for judgement
Random sequence 
generation 
(selection bias)
Low risk "Participants…were randomised to the intervention or control group 
on a 1:1 ratio by nurses opening a serially numbered… envelope."
Allocation 
concealment 
(selection bias)
Low risk Nurses opened a "serially numbered, opaque, sealed envelope 
designating the patient's allocation."
Incomplete outcome 
data (attrition bias)
Low risk No significant differences in numbers lost to follow-up or patients 
who had died or moved away. Those who had died or moved away 
excluded from outcome data; those lost to follow-up counted as 
smokers.
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Hasuo 2004
Methods Country: Japan
Recruitment: Inpatients (all diagnoses) to 1 hospital
Selected: Intending to be quit on day of discharge
Participants Participants: 120 current smokers or recent quitters (smoked in past month)
Diagnoses include cancer (n=37), cardiac (n=57)
Age: not stated
Therapists: Nurse
Interventions 1 Intervention: nurse counselling (3 × 20 min sessions). follow-up (3× at 7, 21, 42 days by telephone) (5 min/
call) [Intensity 4]
2 Control: In hospital: same as intervention (nurse sessions, 3 × 20 min each) but no follow-up contact 
[Intensity 2]
NRT: No
Outcomes Abstinence: Abstinence at 12m (type not stated)
Validation: urinary cotinine at 12m
Died: 6 at 12m
Notes Not clear whether results are self-report or cotinine-validated.
Risk of bias table
Bias Authors'
judgement
Support for judgement
Random sequence 
generation 
(selection bias)
Low risk Computerized randomization stratified by smoking status, FTND, and 
self-efficacy
Allocation 
concealment 
(selection bias)
Low risk Computerized programme randomly assigned individual participants
Incomplete outcome 
data (attrition bias)
Unclear risk More control participants missing outcome data at 12m than 
intervention group (9 versus 5). MA denominators exclude 6 deaths, 
but include 8 who were still smoking on day of discharge. This gives 
marginally larger relative effect.
Haug 2011
Methods Country: Germany
Recruitment: patients admitted in 3 German inpatient rehabilitation centres
Selection: all consecutively admitted patients were assessed by a medical doctor or a nursing staff for inclusion criteria
Participants Participants: 477 current smokers (at least 1 cpd) and recent former smokers (quit for <= 6 months and used to smoke 
at least 1 cpd)
Diagnosis: various acute or chronic disorders (stroke, CHD, cancer, diabetes, asthma,…)
Age: 46.5 yrs av.
Gender: 48% male
Willingness to quit: all stages of change
Therapists: computer expert system
Interventions 1 Intervention: access to an internet-based smoking cessation program with 3 complementary modules during 
6m: up to 7 individual counselling sessions by a computer expert system, information websites and 
message board (individual feedback letters) [Intensity 4]
2 Control: usual care (assessment only)
Pharmacotherapy: not reported
Outcomes Abstinence: self-reported 7-day point prevalence smoking abstinence at 6m
Validation: no
Died: 1 (in control group)
Notes Category: rehabilitation centres
Not clear if intervention began during hospitalisation but probably
OR (Intention to treat analyses) adjusted for rehabilitation centre, baseline stage of change and baseline self-efficacy: 
2.0 (95% CI 1.1–3.7)
Risk of bias table
Bias Authors'
judgement
Support for judgement
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Random sequence 
generation 
(selection bias)
High risk Quasi randomized study. Randomly assigned to intervention or 
control group based on the calendar week of admission.
Allocation 
concealment 
(selection bias)
High risk See above
Incomplete outcome 
data (attrition bias)
Low risk Similar in both groups and ITT analyses
Hennrikus 2005
Methods Country: USA
Recruitment: Inpatients (all diagnoses) admitted to 4 hospitals
Selected: Invited to participate
Participants Participants: 2095 current smokers (smoked in past week and considered self to be regular smoker in month before 
admission)
Age: 47 yrs av.
Therapists: Physician and nurse.
Interventions 1 Intervention: Physician advice to quit (60 seconds) + smoking cessation booklet + additional mailed 
booklet after discharge. [Intensity 1]
2 Intervention: Physician advice to quit (60 seconds) + nurse counselling (motivational interviewing and 
relapse prevention) for 20 min. av. (note: 43% of counselling sessions conducted after discharge by 
telephone rather than at bedside). Follow-up: 3–6 phone calls over 6m (10 min/call median). [Intensity 4]
3 Control: modified usual care: smoking cessation booklet in hospital
NRT: No
Outcomes Abstinence: 7-day PP at 12m
Validation: Saliva cotinine (<15 ng/ml)
Died: 78 at 12m
Notes High and differential levels of refusal to provide validation/mis-reporting
Risk of bias table
Bias Authors'
judgement
Support for judgement
Random sequence 
generation 
(selection bias)
Unclear risk Method of sequence generation not specified
Allocation 
concealment 
(selection bias)
Unclear risk "Research assistants… randomized [participants] to one of three 
treatment conditions by looking up the next available group 
assignment on a list on which the three conditions were randomly 
ordered within blocks of 30 assignments."
Incomplete outcome 
data (attrition bias)
Low risk 78 deaths and ineligible (too ill) for follow-up excluded from 
denominators; all other participants missing data at final follow-up 
counted as smokers. Similar numbers lost to follow-up in all groups.
Lacasse 2008
Methods Country: Canada
Recruitment: patients with expected LOS >=36 hours in 1 tertiary cardiopulmonary centre
Selection: Eligible patients who accepted to participate were immediately assigned to one group
Participants Participants: 196 current smokers
Diagnosis: Mainly cardiology (63%) and pneumology (27%)
Age: 52 yrs av.
Gender: 64–68% male
Willingness to quit: yes, patients in the precontemplation stage of change were excluded
Therapists: counsellors (no further definition)
Interventions 1 Intervention: strong quit smoking message from the treating physician, self-help material, brief cessation 
counselling with counsellor, pharmacology adjuncts. Follow-up: 4 telephone calls within 6 wks post 
discharge. [Intensity 4]
2 Control: usual care, no specific instructions on how to quit smoking
Pharmacotherapy: NRT offered to all patients in the intervention group (18 patients used)
Outcomes Abstinence:7-day PP at 6 and 12 months
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Validation: urinary cotinine (<200 ng/ml) but non validated quit rates used in the meta-analysis
Died: 1 in intervention group
Notes Study stopped early because of lack of efficacy.
Non validated quit rates used in this meta-analysis instead of cotinine validated because only half of participants had 
validation.
Mainly cardiac and pulmonary patients but can't separate results.
Risk of bias table
Bias Authors'
judgement
Support for judgement
Random sequence 
generation 
(selection bias)
Low risk "table of random numbers"
Allocation 
concealment 
(selection bias)
Unclear risk "Those who were eligible and who accepted to participate were 
immediately assigned to either the intervention or the control group 
by one of the hospital pharmacists."
Comment: Method not specified
Incomplete outcome 
data (attrition bias)
Low risk Similar numbers lost in both groups (14/99 intervention, 13/97 usual 
care), "analyses were run according to the intention-to-treat 
principle."
Lewis 1998
Methods Country: USA
Recruitment: Inpatients excluding certain cardiac conditions
Selected: Prepared to make quit attempt
Participants Participants: 185 current smokers.
Number smoked: 24 cpd
Age: 43 yrs av.
12 ICD-9 diagnostic categories
Therapists: Physician and nurse
Interventions 1 Intervention: Physician advice. Counselling (1×, total 2–3 mins, type information). NRT (patch, dose 
22mg, for 3 wks + 11 mg, for 3 wks). Self-help materials. follow-up (4× at 1, 3, 6 wks, 6m by telephone). 
[Intensity 4]
2 Intervention: Physician advice. Counselling (1×, total 2–3 mins, type information). Placebo patch. Self-
help materials. follow-up (4× at 1, 3, 6 wks, 6m by telephone). [Intensity 4]
3 Control: Advice only
NRT: Yes
Outcomes Abstinence: PP at 6m
Validation: Expired air CO
Died: None reported
Notes 1 vs 2 for effect of NRT. 1+2 vs 3 for behavioural counselling intervention analysis.
Highest quit rates found in patients with respiratory disease.
Risk of bias table
Bias Authors' judgement Support for judgement
Random sequence 
generation 
(selection bias)
Low risk "using a predetermined computer-generated randomization code"
Allocation 
concealment 
(selection bias)
Low risk Central allocation
Incomplete outcome 
data (attrition bias)
Unclear risk Drop-out rates not reported, but analyses conducted as ITT
Metz 2007
Methods Country: Germany
Recruitment: patients with length of stay of at least 3 weeks in 13 rehabilitation hospitals treating respiratory diseases, 
CVD, cancer or DM
Selection: not reported
Participants Participants: 307 smokers ≥1 cigarette during the past month
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Diagnosis: Diverse disease (stroke, CHD, cancer, pulmonary disease diabetes, etc)
Age: not reported
Gender: 58.6% male
Willingness to quit: all stages (12.5% precontemplation, 54.6% contemplation, 17.9% preparation, 15% action)
Therapists: therapeutic staff with 3-day training performed the in-hospital interventions and 2 specially trained 
psychologists performed the telephone sessions
Interventions 1 Intervention: 7 sessions lasting 60 min of either cognitive-behavioral or a motivational treatment during 
hospitalisation + 5 proactive telephone booster sessions after discharge (2 during first week after discharge, 
third during 3rd wk, fourth during 5th wk and 5th between 6th and 10th wk). [Intensity 4]
2 Control: 7 sessions lasting 60 min of either cognitive-behavioral or a motivational treatment during 
hospitalisation
Pharmacotherapy: not reported
Outcomes Abstinence:self-reported 7-day PP at 3, 6 and 12m
Validation: none
Died: none reported
Notes Category: Rehabilitation centres and postdischarge intervention
OR (not ITT): 2.18 (95% CI 1.21–3.93)
Risk of bias table
Bias Authors'
judgement
Support for judgement
Random sequence 
generation 
(selection bias)
Unclear risk Randomized, 1:2 ratio, method not described
Allocation 
concealment 
(selection bias)
Unclear risk Allocation method not specified
Incomplete outcome 
data (attrition bias)
High risk 17/316 randomized to I excluded, no contact post discharge. 
Differential drop-out from remainder, 17% Int, 40% Cont. No 
detected differences in characteristics of drop-outs. Sensitivity 
analyses excluding losses to follow-up removes significance.
Meysman 2010
Methods Country: Belgium
Recruitment: patients admitted on surgical wards in 4 university hospitals
Selection: inpatients admitted on surgical wards, recruited within 24 hours of admission
Participants Participants: 358 current smokers of > 10 cpd
Diagnosis: surgical patients (orthopaedics, traumatology, ENT, head and neck surgery and neurosurgery)
Age: 43.2 year av.
Gender: 63% male
Willingness to quit: all stages of change (precontemplation 25%, contemplation 56%, preparation and action 19%)
Therapists: nurse and counsellor
Interventions 1 Intervention: brief nurse-delivered intervention (5 A’s) and referral to smoking cessation counsellor for 
smokers in the preparation/action stage [Intensity 2]
2 Control: booklet with information on smoking cessation
Pharmacotherapy: not reported
Outcomes Abstinence:self-reported continuous abstinence at 6m
Validation: none
Died: none reported
Notes category: surgical patients
Risk of bias table
Bias Authors'
judgement
Support for judgement
Random sequence 
generation 
(selection bias)
Unclear risk Participants stratified by stage of change. Method of randomization 
not specified.
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Allocation 
concealment 
(selection bias)
Unclear risk Not stated
Incomplete outcome 
data (attrition bias)
Unclear risk Patients lost to follow-up counted as smokers, exact numbers not 
provided.
Miller 1997
Methods Country: USA
Recruitment: Inpatients excluding obstetric and psychiatric patients
Selected: Prepared to make quit attempt, those wishing to do so alone excluded
Participants Participants: 1942 current smokers.
Number smoked: 20 cpd
Age: 51 yrs av.
32% with cardiovascular, 12% pulmonary diagnosis
Therapists: Physician and nurse counsellor
Interventions 1 Intervention: Physician advice. Counselling (1×, total 30 mins, type behavioural). Self-help materials, 
relaxation tapes, video. follow-up (4× at 48hr, 1, 3 wks, 3m by telephone) [Intensity 4]
2 Intervention: Physician advice. Counselling (1×, total 30 mins, type behavioural). Self-help materials, 
relaxation tapes, video. follow-up (1× at 48 hr by telephone) [Intensity 3]
3 Control: Advice only
NRT: No
Outcomes Abstinence: Sustained abstinence at 3, 6 & 12m
Validation: Plasma cotinine or family member corroboration
Died: 82 at 12m
Notes 1 vs 3 in intensive comparison, 2 vs 3 in minimal comparison
12 months abstinence (PP) 1+2 vs 3 separately for cardiovascular, pulmonary and other diagnosis.
Risk of bias table
Bias Authors'
judgement
Support for judgement
Random sequence 
generation 
(selection bias)
Unclear risk Method of sequence generation not specified
Allocation 
concealment 
(selection bias)
Low risk "Nurses opened sealed envelopes in front of patients to determine 
patients' assignments."
Incomplete outcome 
data (attrition bias)
Low risk Deaths excluded from MA denominator; all others lost to follow-up 
considered smokers; similar loss to follow-up across all groups 
(10%).
Mohiuddin 2007
Methods Country: USA
Recruitment: Inpatients with diagnosis of acute coronary syndrome (including MI) or decompensated CHF, admitted to 
CCU of 1 hospital
Selected: Invited to participate.
Participants Participants: 209 current smokers who had smoked for 5+ yrs, FTND>7
Number smoked: 24 cpd
Age: 55 yrs av.
Therapists: Physician and trained tobacco counsellor or nurse
Interventions 1 Intervention: Counselling (30 mins, type not specified). Self-help booklet. Free NRT and/or bupropion. 
follow-up: weekly group meetings (60 min session for up to 3m) with trained tobacco counsellor (content: 
behavioural counselling, social support, relaxation training, risk factor management). [Intensity 4]
2 Control: same inpatient component as intervention group: counselling (30 mins, type not specified). Self-
help booklet. Free NRT and/or bupropion. No follow-up offered. [Intensity 2]
NRT: NRT or bupropion offered on individualized basis to both groups
Outcomes Abstinence: Sustained abstinence at 3, 6, 12m. (note: sustained abstinence to 24m reported but not used in pooling)
Validation: CO
Died: 15 at 12m (12 control, 3 intervention)
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Notes 1 vs 2 in intensity 4 subgroup. Same in-hospital intervention; differed in follow-up component only.
Included in CVD subcategory
Risk of bias table
Bias Authors'
judgement
Support for judgement
Random sequence 
generation 
(selection bias)
Unclear risk "Consenting patients were then randomly assigned using simple 
randomization without block assignment."
Comment: method not specified
Allocation 
concealment 
(selection bias)
Unclear risk Method not specified
Incomplete outcome 
data (attrition bias)
Low risk Similar number lost to follow-up in both groups (5/109 intervention, 
4/100 control). Participants lost to follow-up counted as smokers.
Molyneux 2003
Methods Country: UK
Recruitment: Medical and surgical inpatients admitted to 1 hospital
Selected: Invited to participate.
Participants Participants: 274 current smokers (smoked in past month)
Number smoked: 17 cpd
Age: 50 yrs av.
Therapists: Physician or nurse
Interventions 1 Intervention: brief counselling + booklet, no NRT. No follow-up. [Intensity 2]
2 Intervention: brief counselling (20 mins) + booklet + offer of open label NRT×6 wks (choice of gum, 
patch, inhalator, lozenge, nasal spray); 96% used some NRT. No follow-up. [Intensity 2]
3 Control: usual care
NRT: Yes
Outcomes Abstinence: Sustained abstinence at 3, 12m
Validation: CO <10 ppm at 12m
Died: not stated
Notes 1+2 vs 3 for intensity 2 comparison, 2 vs 1v for NRT comparison.
Deaths not stated so not excluded from main analysis.
Risk of bias table
Bias Authors'
judgement
Support for judgement
Random sequence 
generation 
(selection bias)
Unclear risk "Patients were randomised … using a list generated for each centre, 
allocating equally in random permuted blocks of nine".
Allocation 
concealment 
(selection bias)
Unclear risk Not stated
Incomplete outcome 
data (attrition bias)
Low risk Large number lost to follow-up but similar across all groups. Losses 
to follow-up counted as continuing smokers. All losses fully detailed 
in flow chart.
Nagle 2005
Methods Country: Australia
Recruitment: Inpatients (all diagnoses) admitted to 1 teaching hospital (excluded intensive care units)
Selected: Invited to participate
Participants Participants: 1422 current smokers or quitters (smoked in past 12m)
Age: not stated
Therapists: nurse
Interventions 1 Intervention: Nurse counselling (2 × 10 min sessions, type: withdrawal symptom management, coping 
skills) + booklet + offer of NRT in hospital and for 5 days post-discharge (3% received in hospital). follow-
up: none. [Intensity 2]
2 Control: modified usual care (Physician advice + booklet)
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NRT: Yes (partial)
Outcomes Abstinence: 7-day PP at 12m (Continuous self-reported abstinence also given)
Validation: Saliva cotinine <=15 ng/ml
Died: 28 at 12m
Notes Study includes recent quitters (smoked in past year but not in past month); results not stratified by baseline smoking 
status.
Risk of bias table
Bias Authors'
judgement
Support for judgement
Random sequence 
generation 
(selection bias)
Low risk Computerised. "Randomization was based on blocks of 20 patients…
Stratification into recent smoker and recent quitter categories occurred 
prior to randomization."
Allocation 
concealment 
(selection bias)
Low risk "Patients who reported smoking within the last 12 months were 
entered by the research assistant at the patient's bedside into the 
LAPSMOKE program on a laptop computer, which gave an 
immediate random allocation to either control or intervention that 
could not be changed."
Incomplete outcome 
data (attrition bias)
Low risk "At 12 months no difference for completed surveys or for loss to 
follow-up existed between the intervention group and the control 
group." 28 deaths at 12m excluded from denominator, all other 
participants missing data counted as smokers.
Ortega 2011
Methods Country: Spain
Recruitment: patients admitted in 1 hospital
Selection: all hospitalised smokers were asked to enter in the smoking cessation protocol
Participants Participants: 1843 current smokers (smoked > 100 cigarettes lifetime)
Diagnosis: medicine and surgery patients
Age: 61–66
Gender: 83–88% males
Willingness to quit: all stages
Therapists: nurse
Interventions 1 Intervention: cognitive behavioral intervention (30–45 min sessions every 3 days during hospitalisation) + 
NRT (patches or chewing gum) free during hospital for 12 wks + post discharge follow-up: Smoking 
cessation outpatient clinic or telephone calls (patient could chose) at 1, 2 wks, 1, 2, 3, 6, and 12m
2 Control: cognitive behavioral intervention (30–45 min sessions every 3 days during hospitalisation)+ post 
discharge follow-up: Smoking cessation outpatient clinic or telephone calls (patient could chose) at 1, 2 
wks, 1, 2, 3, 6, and 12 month
[Both arms: intensity 4]
Pharmacotherapy: NRT (patches or chewing gums) in intervention group
Outcomes Abstinence: smoking abstinent at 1 year (not more specified)
Validation: CO in subgroup only
Died: none reported
Notes Category: pharmacotherapy
1 extra arm = control who refuse to enter study but not eligible for this meta-analysis
No blinding, no placebo.
Used in NRT comparison only as both arms offered same counselling.
Risk of bias table
Bias Authors'
judgement
Support for judgement
Random sequence 
generation 
(selection bias)
Low risk Participants were randomized using a "computerized algorithm."
Allocation 
concealment 
(selection bias)
Unclear risk Not described
Incomplete outcome 
data (attrition bias)
Unclear risk Number not specified. Participants lost to follow-up included as 
smokers in outcome data.
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Ortigosa 2000
Methods Country: Spain
Recruitment: Inpatients with acute MI
Selected: Invited to participate
Participants Participants: 90 current smokers
Number smoked: 25 cpd
Age: 57 yrs av
Therapists: Physician
Interventions 1 Intervention: Physician advice. follow-up (3× at 2, 3, 4 wks by telephone). [Intensity 3]
2 Control: Usual care
NRT: No
Outcomes Abstinence: PP at 12m.
Validation: Expired air CO.
Died: 3 at 12m.
Notes Intervention not delivered by specialist counsellor.
Included in CVD subcategory.
Risk of bias table
Bias Authors'
judgement
Support for judgement
Random sequence 
generation 
(selection bias)
Unclear risk Stratified randomization, method of sequence generation not specified
Allocation 
concealment 
(selection bias)
Unclear risk Method not specified
Incomplete outcome 
data (attrition bias)
Low risk No participants lost to follow-up. 3 deaths excluded from the analysis.
Pedersen 2005
Methods Country: Denmark
Recruitment: Inpatients with cardiac disease
Selected: Invited to participate
Participants Participants: 105 current smokers (not defined)
Age: not stated
Therapists: not stated
Interventions 1 Intervention: usual hospital protocol: advice to quit + information about NRT + NRT available. follow-up: 
visits 5 times after discharge (30 min/meeting) [Intensity 4]
2 Control: usual care: advice to quit + information about NRT + NRT available.
NRT: Yes (partial)
Outcomes Abstinence: Abstinence (probably PP) at 12m
Validation: none
Died: not stated
Notes Included in CVD subcategory
Risk of bias table
Bias Authors'
judgement
Support for judgement
Random sequence 
generation 
(selection bias)
Unclear risk Not specified
Allocation 
concealment 
(selection bias)
Unclear risk After enrolling, patients drew an envelope containing an allocation. 
No further details about the envelope provided.
Incomplete outcome 
data (attrition bias)
Low risk 10 participants lost to follow-up (7 intervention, 3 control) counted as 
smokers in final analysis.
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Pederson 1991
Methods Country: USA
Recruitment: Inpatients with COPD.
Selected: Invited to participate
Participants Participants: 74 current smokers
Number smoked: 25 cpd
Age: 53 yrs av.
43% chronic bronchitis, 57% emphysema
Therapists: Non-specialist trained in counselling
Interventions 1 Intervention: Physician advice (prior to admission). Counselling (3–9×, total 45–160 mins, type 
information). Self-help materials. No follow-up. [Intensity 2]
2 Control: Advice only
NRT: No
Outcomes Abstinence: PP at 6m
Validation: Serum COHb (in sample)
Died: 8 at 6m
Notes
Risk of bias table
Bias Authors'
judgement
Support for judgement
Random sequence 
generation selection 
bias)
Unclear risk Details not provided
Allocation 
concealment 
(selection bias)
Unclear risk Details not provided
Incomplete outcome 
data (attrition bias)
Low risk 8 deaths excluded, 8 lost to follow-up included and counted as 
smokers. Similar number lost to follow-up in both groups.
Pelletier 1998
Methods Country: Canada
Recruitment: Inpatients with acute MI
Selected: Invited to participate
Participants Participants: 504 current smokers
Age: not stated
Therapists: Nurse
Interventions 1 Intervention: Physician advice. Self-help materials [Intensity 2]
2 Control: Usual care
NRT: No
Outcomes Abstinence: self-reported PP at 12m
Validation: None
Died: Not stated
Notes Included in CVD subcategory
Risk of bias table
Bias Authors'
judgement
Support for judgement
Random sequence 
generation 
(selection bias)
High risk Quasi experimental design. 2 control hospitals, 1 experimental 
hospital.
Allocation 
concealment 
(selection bias)
High risk See above
Incomplete outcome 
data (attrition bias)
Unclear risk Number lost to follow-up not stated.
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Planer 2011
Methods Country: Israel
Recruitment: patients hospitalised for ACS in 2 separate campuses in Jerusalem
Selection: all smokers hospitalised for acute coronary syndrome were approached on their 2nd day of hospitalisation by 
the study nurse
Participants Participants: 151 smokers of > 10 cpd
Diagnosis: acute coronary syndrome
Age: 51.9 yrs av.
Gender: 79.9% male
Willingness to quit: yes, patients required to exhibit intention to quit smoking
Therapists: study physician and research nurse
Interventions 1 Intervention: counselling (at least 15 min of motivational support) during hospitalisation and continued 
after discharge (at least 2 visits with physician and nurse at 1 and 2m and weekly telephone call by nurse 
during first and second month, then monthly telephone calls during rest of the year) + Bupropion for 2m
2 Control: counselling as per 1 + Placebo for 2m
[Both arms: intensity 4]
Pharmacotherapy: Bupropion during 2m in the intervention group
Outcomes Abstinence: self-reported continuous abstinence at 12m
Validation: none
Died: none reported
Notes Category: pharmacotherapy and cardiac patients
Study stopped early after interim analysis indicated no benefit
OR adjusted for age, sex, invasive procedure, risk factors, Fagerstrome score, cpd: 0.90 (95% CI 0.39–2.09)
Risk of bias table
Bias Authors'
judgement
Support for judgement
Random sequence 
generation 
(selection bias)
Unclear risk "Randomized," method not specified
Allocation 
concealment 
(selection bias)
Unclear risk not specified
Incomplete outcome 
data (attrition bias)
Low risk 1 lost to follow-up in each group
Quist-Paulsen 2003
Methods Country: Norway
Recruitment: Inpatients admitted to cardiac ward of 1 general hospital (Diagnoses: MI, unstable angina, post-CABG 
care)
Selected: Invited to participate
Participants Participants: 240 current smokers (smoked daily before symptoms began).
Number smoked: 15 cpd
Age: 57 yrs av.
Therapists: Nurse
Interventions 1 Intervention: Nurse counselling (1–2 times, time not specified, type: fear arousal, advice on using NRT); 
follow-up (5× at 2, 7, 21 days, 3m, 5m) by telephone, clinic visit to cardiac nurse at 6 wks); NRT: Gum or 
patch encouraged for subjects with strong urges to smoke in hospital. [Intensity 4]
2 Control: usual care (advice to quit + booklet)
NRT: Yes
Outcomes Abstinence: PP at 12m
Validation: Urine cotinine <2.0 mmol/mol creatinine
Died: 5 at 12m
Notes Included in CVD subcategory
Risk of bias table
Bias Authors'
judgement
Support for judgement
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Random sequence 
generation 
(selection bias)
Unclear risk "Randomization was in blocks of varying sizes." Method not 
specified.
Allocation 
concealment 
(selection bias)
Low risk "The nurses were given a serially numbered sealed envelope from a 
secretary who was otherwise uninvolved in the study."
Incomplete outcome 
data (attrition bias)
Unclear risk Meta-analysis does not include 5 deaths; all other losses to follow-up 
considered to be smoking but differential loss to follow-up (15 in 
intervention group, 2 in control group).
Reid 2007
Methods Country: Canada
Recruitment: patients admitted in 1 tertiary care cardiac facility
Selection: current smokers who met eligibility criteria were recruited within 24 hours of admission. Patients living > 1 
hour away were excluded
Participants Participants: 99 current smokers ≥ 5 cpd
Diagnosis: ACS, elective PCI or diagnostic catheterization related to CHD
Age: 54
Gender: 61–75% male
Willingness to quit: not assessed
Therapists: nurse
Interventions 1 Intervention: standard in-hospital treatment for smokers (personalized advice to quit smoking, access to 
NRT, brief bedside counselling and self-help guide) + interactive voice response system (IVR) follow-up 
on days 3, 14 and 30 post-discharge [Intensity 3]
2 Control: standard in-hospital treatment for smokers (personalized advice to quit smoking, access to NRT, 
brief bedside counselling and self-help guide)
Pharmacotherapy: access to NRT during hospitalisation for both arms
Outcomes Abstinence: 7-day PP at 12m
Validation: none
Died: 1 in control group
Notes Category: post discharge intervention
Risk of bias table
Bias Authors'judgement Support for judgement
Random sequence 
generation 
(selection bias)
Low risk "mediated through the Clinical Epidemiology Unit’s data centre, 
using a computer generated randomization list"
Allocation 
concealment 
(selection bias)
Low risk "Research staff were unaware of the treatment allocation prior to 
randomization"
Incomplete outcome 
data (attrition bias)
Low risk ~15% lost to follow-up, similar between groups. 1 Control death 
excluded, others included
Rigotti 1994
Methods Country: USA
Recruitment: Inpatients scheduled for CABS
Selected: Invited to participate
Participants Participants: 87 current smokers or recent quitters (38%, defined as at least 1 pack/cigarettes in previous 6m)
Number smoked: 33 cpd
Age: 58 yrs av.
82% of all CABG surgery
Therapists: Nurse
Interventions 1 Intervention: Counselling (3×, total 60 mins, type behavioural). Self-help materials, video. follow-up (1× at 
1 wk by telephone). [Intensity 3]
2 Control: Advice only
NRT: No
Outcomes Abstinence: Sustained abstinence at 4, 8, 12m.
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Validation: Salivary cotinine
Died: 7 at 12m
Notes Abstinence rates include smokers who had quit prior to surgery.
Included in CVD subcategory.
Risk of bias table
Bias Authors'judgement Support for judgement
Random sequence 
generation 
(selection bias)
Unclear risk "Patients were randomly assigned to control or intervention groups 
after surgery." Method not specified.
Allocation 
concealment 
(selection bias)
Unclear risk Not specified
Incomplete outcome 
data (attrition bias)
Low risk 7 deaths not counted in final meta-analysis. No other patients lost to 
follow-up at 12m.
Rigotti 1997
Methods Country: USA
Recruitment: Inpatients in medical or surgical services.
Selected: Invited to participate
Participants Participants: 615 current smokers or recent quitters (proportion not stated, defined as at least 1 cigarette in previous 
month)
Number smoked: 24 cpd
Age: 48 yrs av.
23% had cardiac or pulmonary diagnosis
Therapists: Research assistant and nurse
Interventions 1 Intervention: Physician advice (prompt on chart). Counselling (1×, total 15 mins, type behavioural). Self-
help materials. Follow-up (1–3× at 1–3 wks by telephone); [Intensity 3]
2 Control: Usual care
NRT: 'some' (around 4%).
Outcomes Abstinence: PP at 6m.
Validation: Salivary cotinine
Died: 35 at 12m
Notes 50% of patients could recall being given physician advice.
Risk of bias table
Bias Authors'judgement Support for judgement
Random sequence 
generation 
(selection bias)
Unclear risk Each day's list of eligible smokers put in random order and patients 
recruited consecutively in this order. Randomized by research 
assistant.
Allocation 
concealment 
(selection bias)
Unclear risk See above
Incomplete outcome 
data (attrition bias)
Low risk 73 (22.4%) lost to follow-up included in ITT analysis, no evidence of 
differential loss. 35 (5.4%) deaths excluded.
Rigotti 2006
Methods Country: USA
Recruitment: Inpatients with cardiovascular disease (MI, unstable angina, CHF) or PVD admitted to 5 hospitals
Selected: Invited to participate
Participants Participants: 254 current smokers (smoked in past month) and willing to consider smoking cessation at discharge (no 
commitment required)
Number smoked: 23/21 cpd
Age: 56 yrs av.
Therapists: Nurse
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Interventions 1 Intervention: Bupropion SR 300 mg/day × 12 wks, started in hospital. Nurse counselling (30–45 min, type 
cognitive/behavioural and relapse prevention) in hospital + booklet + follow-up telephone calls (10 min/
call) 5× at 2, 7, 21 days, 2m, 3m. Total counselling time: 85–90 mins.
2 Control: As above, but placebo pill
NRT: No
Outcomes Abstinence: Continuous abstinence at 2, 4, 12, 52 wks.
Validation: Saliva cotinine at 12 and 52 wks, CO at 2 and 4 wks
Died: 2 at 12m
Notes Used for bupropion comparison and CV diagnosis, not for comparison of counselling intensity because both groups had 
same counselling.
Risk of bias table
Bias Authors'judgement Support for judgement
Random sequence 
generation 
(selection bias)
Low risk "Using a computer program, the study statistician generated a 
sequence of randomly-permuted blocks of 4 within strata formed by 
study site and daily cigarette consumption (10 vs 10)."
Allocation 
concealment 
(selection bias)
Low risk "The study pharmacist used this sequence, concealed from enrolment 
staff, to assign participants to study arm. Subjects and study 
personnel, except the statistician and pharmacist, were blind to 
treatment assignment."
Incomplete outcome 
data (attrition bias)
Low risk "Subjects were considered smokers if they were lost to follow-up…"; 
same percentage lost to follow-up in both groups
Simon 1997
Methods Country: USA
Recruitment: Inpatients undergoing non-cardiac surgery
Selected: Prepared to make quit attempt
Participants Participants: 299 current smokers
Number smoked: 20 cpd
Age: 54 yrs av.
Most cardiovascular or respiratory disease
Therapists: Public health educator
Interventions 1 Intervention: Inpatient counselling (1×, total 30–60 mins, type behavioural). Self-help materials, video. 
NRT if no contraindications (gum, dose not stated, for 3m). follow-up (5× at 1–3 wks, 2m, 3m by 
telephone). [Intensity 4]
2 Control: Advice only
NRT: Yes
Outcomes Abstinence: PP at 12m
Validation: Serum or salivary cotinine or corroboration by significant other
Died: 25 at 12m
Notes Appro× 65% intervention and 17% control used NRT. Not associated with quitting in either group.
Risk of bias table
Bias Authors'judgement Support for judgement
Random sequence 
generation 
(selection bias)
Unclear risk "Random list of assignments"
Allocation 
concealment 
(selection bias)
Low risk "Sealed opaque envelopes opened on formal enrolment"
Incomplete outcome 
data (attrition bias)
Low risk 28 lost to follow-up included in ITT analysis, 25 deaths excluded 
from denominator.
Simon 2003
Methods Country: USA
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Recruitment: Inpatients (all diagnoses) admitted to 1 hospital for military veterans
Selected: Invited to participate
Participants Participants: 223 current smokers (smoked >=20 cigarettes in wk before admission), contemplation or action stage of 
change, able to use NRT.
Number smoked: 23 cpd
Age: 55 yrs av.
Therapists: Nurse or health educator
Interventions 1 Intervention: Nurse or health educator counselling (30–60 mins; type cognitive/behavioural) + booklet + 
NRT patches × 8 wks. follow-up: 5× at 1,3 wks and 1m, 2m, 3m (<30 min/call) [Intensity 4]
2 Control: brief counselling (10 mins) + booklet + NRT patches × 8 wks. No follow-up contact.
NRT: Yes
Outcomes Abstinence: 7-day PP at 12m
Validation: Saliva cotinine <15 ng/ml OR spousal corroboration
Died: 14 at 12m.
Notes Study tests marginal efficacy of counselling in setting of NRT.
Risk of bias table
Bias Authors'judgement Support for judgement
Random sequence 
generation 
(selection bias)
Low risk "Randomly assigned using computerized algorithm"
Allocation 
concealment 
(selection bias)
Unclear risk No details provided
Incomplete outcome 
data (attrition bias)
Low risk 7 (3%) lost to follow-up included in ITT analysis, 14 (6%) died & 
excluded from denominator
Simon 2009
Methods Country: United States
Recruitment: patients admitted in 1 VA hospital
Selection: all smokers hospitalised ≥ 24h screened for eligibility (exclusion criteria: CI to Bupropion, admitted for 
ACS, terminally ill, serious unstable psychiatric illness, family history of seizure, women pregnant or lactating, history 
of drug abuse consumption of >= 3 alcoholic beverages/d)
Participants Participants: 85 smokers ≥ 5cpd during previous year and smoking the week prior admission
Diagnosis: not specified
Age: 56 yrs av.
Gender: 96% male
Willingness to quit: not assessed
Therapists: public health educator
Interventions 1 Intervention: Bupropion during 7wks + counselling (1 cognitive behavioral intervention of 30–60 minutes 
during hospitalisation) + telephone counselling after discharge at wk 1, 3, month 1, 2,
2 Control: Placebo + counselling as above
[Both arms: intensity 4]
Pharmacotherapy: Bupropion in intervention group
Outcomes Abstinence: 7-day PP at 6m
Validation: salivary cotinine
Died: 2 (1 in each group)
Notes Category: pharmacotherapy
Not used in primary meta-analysis by counselling intensity as both arms received same counselling.
Risk of bias table
Bias Authors'judgement Support for judgement
Random sequence 
generation 
(selection bias)
Low risk "computer algorithm to generate a random list of treatment 
assignments."
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Allocation 
concealment 
(selection bias)
Unclear risk "All study personnel engaged in providing interventions to 
participants were blinded to treatment assignment."
Comment: not explicit that this included enrolment staff.
Incomplete outcome 
data (attrition bias)
Low risk Similar number lost to follow-up in both groups. All except deaths 
included in MA.
Smith 2009
Methods Country: Canada
Recruitment: patients admitted in 4 cardiac units in a large urban hospital
Selection: sequential patients admitted for acute MI or CABG who met inclusion criteria were included
Participants Participants: 276 patients who used tobacco in the month before admission
Diagnosis: acute MI or CABG
Age: 54 yrs av.
Gender: 82–83% male
Willingness to quit: ranged from 3–7, mean 6.8 (on a 1–7 scale, with 7 = full intention)
Therapists: nurse
Interventions 1 Intervention:minimal intervention + 45–60 minutes of bedside education and counselling, take-home 
material and 7 telephone counselling sessions at 2, 7, 14, 21, 30, 45, and 60 days after discharge. [Intensity 
4]
2 Control: : minimal intervention: research nurse advice smoker to quit, review 2 pamphlets and asked the 
attending physician to give a scripted nonsmoking message.
Pharmacotherapy: not part of the study but available through hospital if requested
Outcomes Abstinence: 7-day PP and continuous abstinence at 12m
Validation: proxy corroboration at 12m only for 7-day PP only
Died: 4 (2 in each group)
Notes Category: cardiac patients
For the meta-analysis we used validated 7-day PP
Risk of bias table
Bias Authors'judgement Support for judgement
Random sequence 
generation 
(selection bias)
Low risk "… randomization code using a computer random-number generator 
to select random permuted blocks of 10… stratified by acute MI and 
CABG."
Allocation 
concealment 
(selection bias)
Unclear risk The nurse "opened the randomization envelope and informed the 
patients of intervention assignment (intensive or minimal)."
Comment: no details of envelope
Incomplete outcome 
data (attrition bias)
Low risk Participants lost to follow-up counted as smokers. Similar percentage 
lost to follow-up in both groups (9.4% control, 8.8% intervention).
Smith BJ 2011
Methods Country: Australia
Recruitment: patients with smoking-related diseases admitted on pulmonary, cardiology, neurology, vascular or general 
medicine wards in 3 hospitals
Selection: patients who agree to make a serious smoking cessation attempt, plan to return home were included
Participants Participants: 392 current smoker (≥ 10 cpd on average in past year)
Diagnosis: smoking related in respiratory, cardiology, neurology, or vascular medicine
Age: 18–75
Gender: both
Willingness to quit: yes (only patients willing to make a serious smoking cessation attempt were included)
Therapists: Quitline counsellors at Quit SA (South Australia quitline)
Interventions 1 Intervention: initial contact with quitline made in hospital at bedside; also got booklet + Varenicline 
(standard titration to 1 mg bid × 12 wk) + follow-up: Quitline (Quit SA) - 8 scheduled calls over 12 wks, 5–
10 min each call
2 Control: counselling as above
[Both arms: intensity 4]
Pharmacotherapy: Varenicline in intervention group
Outcomes Abstinence: continuous abstinence (2–52 weeks) defined as <=5 cigarettes during 12 months
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Validation: a random subsample was CO validated, but we use self report
Died: 13 (7 in control and 6 in intervention group)
Notes Category: pharmacotherapy.
Data from abstract and unpublished manuscript only.
Open label (varenicline vs. no varenicline).
Not included in primary meta-analysis as both arms received same counselling.
Risk of bias table
Bias Authors'judgement Support for judgement
Random sequence 
generation 
(selection bias)
Low risk A pre-defined, central, computer-generated randomisation sequence 
was used to assign subjects in a 1:1 ratio to either intervention or 
control
Allocation 
concealment 
(selection bias)
Low risk Allocation concealment was achieved using opaque, sealed envelopes 
with consecutive numbers
Incomplete outcome 
data (attrition bias)
Low risk low risk (>80% follow-up in both groups)
Smith PM 2011
Methods Country: Canada
Recruitment: patients admitted in 3 community hospitals
Selection: study nurses approached eligible patients
Participants Participants: 643 current smokers (tobacco use in the last 30 days)
Diagnosis: diverse (CVD, pulmonary, other internal medicine, cancer, orthopaedic, gynaecology, non cardiac surgery)
Age: 49 yrs av.
Gender: 49.3% male
Willingness to quit: yes
Therapists: nurses
Interventions 1 Intervention:brief intervention + in hospital education, take home materials, counselling and post-discharge 
telephone counselling: post-discharge telephone counselling (5–10 min/call) for the intervention group at 2, 
7, 14, 21, 30, 45 and 60 days. [Intensity 4]
2 Control: brief intervention (5 minutes): cessation advice personalized to patient’s medical conditions and 2 
pamphlets + note in patient’s chart for the attending physician to provide a message personalized to 
patient’s medical condition.
Pharmacotherapy: not provided
Outcomes Abstinence: self-reported 7 day point-prevalence abstinence at 12m
Validation: with saliva cotinine (< 15 ng/mL) or proxy confirmation at 1 year only
Died: 27 (19 in control and 8 in intervention group)
Notes
Risk of bias table
Bias Authors'judgement Support for judgement
Random sequence 
generation 
(selection bias)
Low risk computerized random number generator
Allocation 
concealment 
(selection bias)
Unclear risk not specified, randomization envelopes
Incomplete outcome 
data (attrition bias)
Low risk Participants lost to follow-up counted as smokers but not specified, 
deaths excluded from final denominators
Steinberg 2011
Methods Country: USA
Recruitment: patients admitted in 1 university-based hospital
Selection:patients approached within 24–48h after admission, hospital computer system identified all patients
Participants Participants: 79 smokers (smoking ≥ 10 cpd within the past month)
Diagnosis: various diagnoses (CVD, orthopedic, pulmonary, other)
Age: 51 yrs av.
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Gender: 59 % male
Willingness to quit: not specified
Therapists: tobacco treatment specialist
Interventions 1 Intervention: Varenicline (12 wks) + during hospitalisation: personalized strong quit message, printed 
information on behavioral change, outpatient quit resources (Quitline, Quitnet, local tobacco dependence 
program) + brief behavioral treatment after discharge at a local Tobacco Dependence Treatment (weekly 
follow-up sessions for 6 wks after discharge followed by monthly follow-up sessions × 4 or 5 to get them 
out to 6m after discharge.
2 Control: Placebo (12 weeks) + same as intervention group
[Both arms: intensity 4]
Pharmacotherapy: Varenicline in intervention group
Outcomes Abstinence: sustained abstinence at 6 months (abstinent at 4w, 12w & 6m visits)
Validation: expired CO (<8ppm)
Died: 0
Notes OR adjusted for age, race, education and level of dependence 0.34 (95% CI 0.10–1.23)
Risk of bias table
Bias Authors'judgement Support for judgement
Random sequence 
generation 
(selection bias)
Low risk "randomized in a 1:1 ratio through centralized telephone 
randomization process by the study statistician and hospital research 
pharmacist"
Allocation 
concealment 
(selection bias)
Low risk See above
Incomplete outcome 
data (attrition bias)
Low risk ITT analysis conducted; unvalidated smoking status included where 
ascertained for non-attenders; lost to follow-up the same in 2 groups
Stevens 1993
Methods Country: USA
Recruitment: Inpatients with stay >36 hrs excluding postpartum and psychiatric patients.
Selected: Invited to participate
Participants Participants: 1119 current smokers or recent quitters (5%, defined as smoking regularly at any time in previous 3m)
Number smoked: 20 cpd
Age: 44 yrs av.
17% cardiovascular or respiratory diagnosis
Therapists: Masters level cessation counsellors
Interventions 1 Intervention: Counselling (1×, total 20 mins, type behavioural). Self-help materials, video. follow-up (1–2× 
at 1–3 wks by telephone); [Intensity 3]
2 Control: Usual care
NRT: No
Outcomes Abstinence: Sustained abstinence at 3 and 12m
Validation: None (low success in obtaining cotinine returns)
Died: None reported
Notes No significant baseline differences between patient characteristics in intervention and control.
Risk of bias table
Bias Authors'judgement Support for judgement
Random sequence 
generation 
(selection bias)
High risk Not random, intervention alternated between hospitals on a monthly 
basis in order to avoid contamination
Allocation 
concealment 
(selection bias)
High risk Intervention or control status of hospital known when patients 
recruited
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Incomplete outcome 
data (attrition bias)
Low risk 6% loss to follow-up, no difference by group, included in ITT 
analysis
Stevens 2000
Methods Country: USA
Recruitment: Inpatients with stay >36 hours excluding postpartum and psychiatric patients
Selected: Invited to participate
Participants Participants: 1173 current smokers or recent quitters (proportion not stated, defined as smoking regularly at any time in 
previous 3m)
Numbers smoked: 19 cpd
Age: 47 yrs av.
Therapists: Respiratory therapist
Interventions 1 Intervention: Counselling (1×, total 20 mins, type behavioural). Self-help materials, video. follow-up (1× at 
1 wk by telephone) [Intensity 3]
2 Control: Usual care
NRT: No
Outcomes Abstinence: Sustained abstinence at 6 and 12m
Validation: None
Died: None reported
Notes Only 68% of intervention group actually offered intervention.
Risk of bias table
Bias Authors'judgement Support for judgement
Random sequence 
generation 
(selection bias)
High risk "Eligible smokers in each hospital were assigned to treatment or usual 
care by a random digit in their HMO member number."
Allocation 
concealment 
(selection bias)
High risk See above.
Incomplete outcome 
data (attrition bias)
Unclear risk Number lost to follow-up not specified. All not contacted at 1 year 
were counted as smokers.
Taylor 1990
Methods Country: USA
Recruitment: Inpatients with acute MI.
Selected: Invited to participate if prepared to make a quit attempt
Participants Participants: 173 current smokers (within last 6m)
Number smoked: 25 cpd
Age: 58 yrs av.
10% previous MI
Therapists: Nurse
Interventions 1 Intervention: Counselling (1×, total not stated, type behavioural), Self-help materials, relaxation tapes. 
NRT (gum 'available', dose not stated, period not stated). follow-up (6–7× at 1–3 wks, every month for 4m 
by telephone); [Intensity 4]
2 Control: Usual care.
NRT: Yes (partial)
Outcomes Abstinence: Sustained abstinence at 3 and 12m.
Validation: Serum thiocyanate, expired air CO
Died: 7 at 12m
Notes NRT gum prescribed to 5 patients.
Risk of bias table
Bias Authors'judgement Support for judgement
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Random sequence 
generation 
(selection bias)
Low risk "A random list of odd and even numbers was generated"
Allocation 
concealment 
(selection bias)
Low risk "a sequence of numbers sealed in envelopes was created…the nurse 
assessing the intervention called the nurse coordinator who opened 
the next envelope to determine the condition to which the patient 
would be assigned"
Incomplete outcome 
data (attrition bias)
High risk 14/86 patients in intervention group and 29/87 patients in control 
group missing data at 12m follow-up. Higher loss to follow-up in 
control group increases apparent effect of intervention when using 
ITT approach, so denominators in MA based on numbers followed-
up.
Vial 2002
Methods Country: Australia
Recruitment: Inpatients (medical and surgical wards) of 1 teaching hospital
Selected: Willing to stop smoking
Participants Participants: 102 current smokers (>= 10 cpd)
Number smoked: not stated
Age: not stated
Therapists: Pharmacist
Interventions 1 Intervention: Pharmacist consultation about NRT use (30–45 mins)+ booklet + up to 16 wks patches at 
half-price. Follow-up: weekly visits × <=16 to obtain patches from hospital pharmacist.
2 Intervention as above, but follow-up patches supplied by community-based pharmacist
[Arms 1 and 2: intensity 4]
3 Control: usual care: advice to quit + booklet
NRT: Yes
Outcomes Abstinence: Sustained abstinence at 3, 6, 12m.
Validation: CO test 'whenever possible' - frequency not stated
Died: not stated
Notes Smoking cessation counselling not clearly done (pharmacist consultation about NRT) ; deletion of study does not 
change results.
1&2 compared to 3 in both the intensity analysis and the NRT efficacy analysis.
Risk of bias table
Bias Authors'judgement Support for judgement
Random sequence 
generation 
(selection bias)
Low risk "consenting patients were randomized in blocks of ten using 
computer-generated random numbers"
Allocation 
concealment 
(selection bias)
Low risk Centralized, see above.
Incomplete outcome 
data (attrition bias)
Unclear risk Follow-up incomplete due to time constraints; analysis therefore does 
not include all participants randomized. 64 out of 102 participants 
included in 12m data, 19 of whom lost to follow-up.
Footnotes
Intensity of intervention: 1. Single contact in hospital lasting <= 15 mins, no follow-up support. 2. One or more contacts in hospital lasting in 
total > 15 mins, no follow-up support. 3. Any hospital contact plus follow-up <=1 month. 4. Any hospital contact plus follow-up > 1 month.
Abbreviations: ACS: acute coronary syndrome; av: average; CABG/S: coronary artery bypass graft/surgery; CCU: coronary care unit; CHD: 
coronary heart disease; CHF: congestive heart failure; CI: confidence interval; CO: carbon monoxide; COPD: Chronic Obstructive Pulmonary 
Disease; cpd: cigarettes per day; CVD: cardiovascular disease; FTND: Fagerstrom Test for Nicotine Dependence; m: month(s); MI: myocardial 
infarction; NRT: nicotine replacement therapy; OR: odds ratio; PCI: percutaneous coronary intervention; PP: point prevalence; PVD: peripheral 
vascular disease; yrs: years
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Characteristics of excluded studies
Agewall 2001
Reason for exclusion Multifactorial intervention. No smoking cessation outcomes reported.
Allen 1998
Reason for exclusion Intervention not delivered in inpatient setting.
Asfar 2005
Reason for exclusion Intervention not delivered in inpatient setting.
Avanzini 2011
Reason for exclusion Case control study.
Becker 2003
Reason for exclusion Participants admitted to observation unit for less than 24 hour hospital stay. Insufficient data.
Bize 2006
Reason for exclusion Not randomized (uses historical controls).
Blom 2005
Reason for exclusion Intervention not delivered in inpatient setting.
BTS 1983
Reason for exclusion Included both inpatient and outpatient data (results for inpatients alone not available).
Burt 1974
Reason for exclusion Not randomized.
Chan 2003
Reason for exclusion Intervention not delivered in inpatient setting.
Chan 2010
Reason for exclusion Coronary heart disease patients recruited in outpatient clinics.
Choo 2004
Reason for exclusion Short follow-up (1m).
Colby 1998
Reason for exclusion Short follow-up (3m). Enrolled only adolescents.
Cole 2001
Reason for exclusion Review article (no new data).
Dale 1995
Reason for exclusion Intervention not delivered in inpatient setting (some participants admitted to inpatient unit for smoking intervention).
Davies 2005
Reason for exclusion Insufficient data on cessation outcome.
Elsony 2005
Reason for exclusion Intervention not delivered in inpatient setting.
Emmons 2000
Reason for exclusion Baseline and pharmacy data from a trial. Main outcomes not reported.
Freund 2009
Reason for exclusion Smoking behavior is not measured as outcome.
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Fung 2005
Reason for exclusion Not randomized.
Gadomski 2011
Reason for exclusion Not randomized.
Galvin 2001
Reason for exclusion Intervention not delivered in inpatient setting.
Gariti 2002
Reason for exclusion Participants were inpatients in a substance abuse treatment unit.
Gies 2008
Reason for exclusion Follow-up too short (3 months).
Gritz 1993
Reason for exclusion Intervention not delivered in inpatient setting (only recruitment carried out in hospital setting).
Hand 2002
Reason for exclusion Included both inpatient and outpatient data (results for inpatients alone not available).
Hanssen 2007
Reason for exclusion Intervention after hospital discharge, intervention was secondary prevention (general cardiac rehab intervention), not 
limited to smokers.
Hasan 2007
Reason for exclusion Not randomized (patients could chose their treatment), tested hypnotherapy
Hilleman 2004
Reason for exclusion Not randomized.
Holmes-Rovner 2008
Reason for exclusion Recruitment after hospital discharge, intervention was secondary prevention, not limited to smokers, and insufficient 
data in article to calculate quit rates.
Horn 2008
Reason for exclusion Intervention in emergency department, not inpatients, teens. No smoking cessation outcome.
Jeong 2002
Reason for exclusion Multifactorial intervention with little smoking cessation content.
Johnson 1999
Reason for exclusion Not randomized.
Jones 2001
Reason for exclusion Intervention delivered after discharge from ITU.
Joseph 2004
Reason for exclusion Participants inpatients for substance abuse treatment.
Joseph 2005
Reason for exclusion Intervention goal smoking reduction, not cessation (enrolled only smokers who do not plan to quit).
Kalman 2001
Reason for exclusion Participants inpatients for alcohol dependence treatment.
Lewis 2009
Reason for exclusion Enrolled outpatients and inpatients; inpatients not analysed separately in article.
Lisspers 1999
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Reason for exclusion Intervention delivered after discharge following PTCA.
McHugh 2001
Reason for exclusion Multicomponent intervention delivered prior to hospitalisation for CABG.
Meenan 1998
Reason for exclusion Not randomised.
Moller 2002
Reason for exclusion Intervention delivered prior to hospital admission.
Mosca 2010
Reason for exclusion Does not only recruit smokers; insufficient data to calculate quit rates. Assesses the impact of a systematic hospital-
based educational intervention among women hospitalised with CHD.
Nackaerts 2009
Reason for exclusion No data for 6m quit rates
Nasell 2010
Reason for exclusion Outcome is postoperative complications and not smoking cessation.
Ong 2005
Reason for exclusion Not an RCT.
Ranote 2003
Reason for exclusion Not an RCT (quasi-experimental design). Abstract only. Insufficient data.
Ratner 2004
Reason for exclusion Intervention delivered prior to hospital admission.
Regan 2011
Reason for exclusion Follow-up too short (12 wks).
Reid 2006
Reason for exclusion Not an RCT (uncontrolled cohort study).
Richman 2000
Reason for exclusion Patients not admitted to hospital, follow-up 3m.
Rissel 2000
Reason for exclusion Intervention delivered to outpatients. Not randomized.
Schmitz 1999
Reason for exclusion No control / usual care group.
Smith 2002
Reason for exclusion Not an RCT (evaluates real world effect of intervention used in DeBusk 1994, Miller 1997 and Taylor 1990).
Strecher 1985
Reason for exclusion Not randomized.
Sundblad 2008
Reason for exclusion Intervention starts before hospital stay; this is a residential smoking cessation program.
Takahashi 2006
Reason for exclusion Intervention not delivered in inpatient setting.
Targhetta 2011
Reason for exclusion No follow-up assessment after discharge.
Taylor 2005
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Reason for exclusion Not an RCT (observational study only).
Thomsen 2010
Reason for exclusion Does not start in hospital but before hospitalisation.
Wakefield 2004
Reason for exclusion Intervention not delivered in inpatient setting.
Warner 2005
Reason for exclusion Intervention not delivered in inpatient setting (prior to hospital admission).
Wewers 1994
Reason for exclusion Short follow-up (5 wks).
Winickoff 2010
Reason for exclusion Subjects are not hospital patients but the parents of hospitalised children.
Wolfenden 2005
Reason for exclusion Intervention not delivered in inpatient setting (begun pre-operatively).
Wolfenden 2008
Reason for exclusion Not an RCT, starts before hospital admission.
Footnotes
CABG: coronary artery bypass graft; ITU: Intensive Therapy Unit; m: month(s); PTCA: percutaneous transluminal coronary angioplasty; wk(s): 
week(s)
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Characteristics of studies awaiting classification
Brunner-Frandsen 2010
Methods
Participants
Interventions
Outcomes
Notes
Jimenez 2007
Methods
Participants
Interventions
Outcomes
Notes
Footnotes
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